<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:51:27Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8294497" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8294497</identifier>
        <datestamp>2021-07-31</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" xml:lang="en" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8294497</article-id>
              <article-id pub-id-type="pmcid">PMC8294497</article-id>
              <article-id pub-id-type="pmc-uid">8294497</article-id>
              <article-id pub-id-type="pmid">34288969</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0254826</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-21-03868</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>North America</subject>
                      <subj-group>
                        <subject>Mexico</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Viral Diseases</subject>
                        <subj-group>
                          <subject>Covid 19</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Mathematical and Statistical Techniques</subject>
                    <subj-group>
                      <subject>Statistical Methods</subject>
                      <subj-group>
                        <subject>Forecasting</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Statistics</subject>
                      <subj-group>
                        <subject>Statistical Methods</subject>
                        <subj-group>
                          <subject>Forecasting</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Pandemics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Sociology</subject>
                    <subj-group>
                      <subject>Communications</subject>
                      <subj-group>
                        <subject>Social Communication</subject>
                        <subj-group>
                          <subject>Social Media</subject>
                          <subj-group>
                            <subject>Twitter</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Computer and Information Sciences</subject>
                  <subj-group>
                    <subject>Network Analysis</subject>
                    <subj-group>
                      <subject>Social Networks</subject>
                      <subj-group>
                        <subject>Social Media</subject>
                        <subj-group>
                          <subject>Twitter</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Sociology</subject>
                    <subj-group>
                      <subject>Social Networks</subject>
                      <subj-group>
                        <subject>Social Media</subject>
                        <subj-group>
                          <subject>Twitter</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Coronaviruses</subject>
                          <subj-group>
                            <subject>SARS coronavirus</subject>
                            <subj-group>
                              <subject>SARS CoV 2</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical microbiology</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Coronaviruses</subject>
                            <subj-group>
                              <subject>SARS coronavirus</subject>
                              <subj-group>
                                <subject>SARS CoV 2</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Pathology and laboratory medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Coronaviruses</subject>
                            <subj-group>
                              <subject>SARS coronavirus</subject>
                              <subj-group>
                                <subject>SARS CoV 2</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral pathogens</subject>
                        <subj-group>
                          <subject>Coronaviruses</subject>
                          <subj-group>
                            <subject>SARS coronavirus</subject>
                            <subj-group>
                              <subject>SARS CoV 2</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Infectious Disease Control</subject>
                        <subj-group>
                          <subject>Social Distancing</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020</article-title>
                <alt-title alt-title-type="running-head">Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2344-5398</contrib-id>
                  <name>
                    <surname>Tariq</surname>
                    <given-names>Amna</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Project administration</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8499-824X</contrib-id>
                  <name>
                    <surname>Banda</surname>
                    <given-names>Juan M.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4007-5624</contrib-id>
                  <name>
                    <surname>Skums</surname>
                    <given-names>Pavel</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dahal</surname>
                    <given-names>Sushma</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8426-211X</contrib-id>
                  <name>
                    <surname>Castillo-Garsow</surname>
                    <given-names>Carlos</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6280-3277</contrib-id>
                  <name>
                    <surname>Espinoza</surname>
                    <given-names>Baltazar</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7294-6810</contrib-id>
                  <name>
                    <surname>Brizuela</surname>
                    <given-names>Noel G.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Saenz</surname>
                    <given-names>Roberto A.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kirpich</surname>
                    <given-names>Alexander</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Luo</surname>
                    <given-names>Ruiyan</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7406-0338</contrib-id>
                  <name>
                    <surname>Srivastava</surname>
                    <given-names>Anuj</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1943-6712</contrib-id>
                  <name>
                    <surname>Gutierrez</surname>
                    <given-names>Humberto</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4700-8192</contrib-id>
                  <name>
                    <surname>Chan</surname>
                    <given-names>Nestor Garcia</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bento</surname>
                    <given-names>Ana I.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3804-9761</contrib-id>
                  <name>
                    <surname>Jimenez-Corona</surname>
                    <given-names>Maria-Eugenia</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chowell</surname>
                    <given-names>Gerardo</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Project administration</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Computer Science, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Mathematics, Eastern Washington University, Cheney, Washington, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Biocomplexity Institute and Initiative, Network Systems Science and Advanced Computing Division, University of Virginia, Charlottesville, Virginia, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Facultad de Ciencias, Universidad de Colima, Colima, Mexico</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Department of Statistics, Florida State University, Tallahassee, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Department of Physics, Centro Universitario de Ciencias Exactas e Ingenierias (CUCEI), University of Guadalajara, Guadalajara, Mexico</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Department of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, Indiana, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>Department of Epidemiology, National Institute of Cardiology "Ignacio Chavez", Mexico City, Mexico</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Adrish</surname>
                    <given-names>Muhammad</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>BronxCare Health System, Affiliated with Icahn School of Medicine at Mount Sinai, NY, USA, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors declare no conflict of interest.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>atariq1@student.gsu.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>21</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>16</volume>
              <issue>7</issue>
              <elocation-id>e0254826</elocation-id>
              <history>
                <date date-type="received">
                  <day>4</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>4</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Tariq et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Tariq et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0254826.pdf"/>
              <abstract>
                <p>Mexico has experienced one of the highest COVID-19 mortality rates in the world. A delayed implementation of social distancing interventions in late March 2020 and a phased reopening of the country in June 2020 has facilitated sustained disease transmission in the region. In this study we systematically generate and compare 30-day ahead forecasts using previously validated growth models based on mortality trends from the Institute for Health Metrics and Evaluation for Mexico and Mexico City in near real-time. Moreover, we estimate reproduction numbers for SARS-CoV-2 based on the methods that rely on genomic data as well as case incidence data. Subsequently, functional data analysis techniques are utilized to analyze the shapes of COVID-19 growth rate curves at the state level to characterize the spatiotemporal transmission patterns of SARS-CoV-2. The early estimates of the reproduction number for Mexico were estimated between <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> ~1.1–1.3 from the genomic and case incidence data. Moreover, the mean estimate of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> has fluctuated around ~1.0 from late July till end of September 2020. The spatial analysis characterizes the state-level dynamics of COVID-19 into four groups with distinct epidemic trajectories based on epidemic growth rates. Our results show that the sequential mortality forecasts from the GLM and Richards model predict a downward trend in the number of deaths for all thirteen forecast periods for Mexico and Mexico City. However, the sub-epidemic and IHME models perform better predicting a more realistic stable trajectory of COVID-19 mortality trends for the last three forecast periods (09/21-10/21, 09/28-10/27, 09/28-10/27) for Mexico and Mexico City. Our findings indicate that phenomenological models are useful tools for short-term epidemic forecasting albeit forecasts need to be interpreted with caution given the dynamic implementation and lifting of social distancing measures.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008982</institution-id>
                      <institution>national science foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 GM 130900.</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Chowell</surname>
                      <given-names>Gerardo</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>national institutes of health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1R01EB025022</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4007-5624</contrib-id>
                    <name>
                      <surname>Skums</surname>
                      <given-names>Pavel</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000001</institution-id>
                      <institution>National Science Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1610429</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Chowell</surname>
                      <given-names>Gerardo</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000001</institution-id>
                      <institution>National Science Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1633381</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Chowell</surname>
                      <given-names>Gerardo</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution>georgia state university</institution>
                  </funding-source>
                  <award-id>2CI fellowship</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2344-5398</contrib-id>
                    <name>
                      <surname>Tariq</surname>
                      <given-names>Amna</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000001</institution-id>
                      <institution>National Science Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>2047828</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4007-5624</contrib-id>
                    <name>
                      <surname>Skums</surname>
                      <given-names>Pavel</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>G.C. is partially supported from NSF grants 1610429 and 1633381 and R01 GM 130900. A.T. is supported by a 2CI fellowship from Georgia State University. P.S. is supported by the National Institutes of Health grant 1R01EB025022 and by the National Science Foundation grant 2047828.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="12"/>
                <table-count count="3"/>
                <page-count count="34"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Mortality data is available from the IHME estimates download webpage: <ext-link xlink:href="http://www.healthdata.org/covid/data-downloads" ext-link-type="uri">http://www.healthdata.org/covid/data-downloads</ext-link> Apple mobility trends data is available from Apple's mobility trends page: <ext-link xlink:href="https://covid19.apple.com/mobility" ext-link-type="uri">https://covid19.apple.com/mobility</ext-link> Case incidence data is available form the Mexican Ministry of Health webpage:<ext-link xlink:href="https://www.gob.mx/salud/documentos/datos-abiertos-152127" ext-link-type="uri">https://www.gob.mx/salud/documentos/datos-abiertos-152127</ext-link> Genomic data is available from the GSAID repository: <ext-link xlink:href="https://www.gisaid.org/" ext-link-type="uri">https://www.gisaid.org/</ext-link> Twitter data is available from the twitter page: <ext-link xlink:href="https://twitter.com/explore" ext-link-type="uri">https://twitter.com/explore</ext-link>.</meta-value>
                </custom-meta>
                <custom-meta id="outbreaks">
                  <meta-name>Outbreaks</meta-name>
                  <meta-value>COVID-19</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Mortality data is available from the IHME estimates download webpage: <ext-link xlink:href="http://www.healthdata.org/covid/data-downloads" ext-link-type="uri">http://www.healthdata.org/covid/data-downloads</ext-link> Apple mobility trends data is available from Apple's mobility trends page: <ext-link xlink:href="https://covid19.apple.com/mobility" ext-link-type="uri">https://covid19.apple.com/mobility</ext-link> Case incidence data is available form the Mexican Ministry of Health webpage:<ext-link xlink:href="https://www.gob.mx/salud/documentos/datos-abiertos-152127" ext-link-type="uri">https://www.gob.mx/salud/documentos/datos-abiertos-152127</ext-link> Genomic data is available from the GSAID repository: <ext-link xlink:href="https://www.gisaid.org/" ext-link-type="uri">https://www.gisaid.org/</ext-link> Twitter data is available from the twitter page: <ext-link xlink:href="https://twitter.com/explore" ext-link-type="uri">https://twitter.com/explore</ext-link>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>The ongoing COVID-19 (coronavirus disease 2019) pandemic is the most important global health challenge since the 1918 influenza pandemic that was caused by an A/H1N1 virus of avian origin [<xref rid="pone.0254826.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0254826.ref002" ref-type="bibr">2</xref>]. The severity of the COVID-19 pandemic calls for scientists, health professionals, and policymakers to collaboratively address the challenges posed by this lethal infectious disease. The causative SARS-CoV-2 (severe acute respiratory syndrome virus 2) is a novel, unusually complex, and highly transmissible virus that spreads via respiratory droplets and aerosols [<xref rid="pone.0254826.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0254826.ref004" ref-type="bibr">4</xref>]. It presents a clinical spectrum that ranges from asymptomatic individuals to conditions that require the use of mechanical ventilation to multiorgan failure and septic shock leading to death [<xref rid="pone.0254826.ref003" ref-type="bibr">3</xref>]. The ongoing COVID-19 pandemic has not only exerted significant morbidity but also an excruciating mortality burden with more than 79.2 million cases and 1.7 million deaths reported worldwide as of December 29, 2020 [<xref rid="pone.0254826.ref005" ref-type="bibr">5</xref>]. Approximately 27 countries globally including 9 countries in the Americas have reported more than 10,000 deaths attributable to SARS-CoV-2 as of December 29, 2020, despite the implementation of social distancing policies to limit the death toll [<xref rid="pone.0254826.ref006" ref-type="bibr">6</xref>]. In comparison, a total of 774 deaths were reported during the 2003 SARS multi-country epidemic and 858 deaths were reported during the 2012 MERS epidemic in Saudi Arabia [<xref rid="pone.0254826.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0254826.ref008" ref-type="bibr">8</xref>].</p>
              <p>Determining the best containment strategies for the COVID-19 pandemic is a highly active research area [<xref rid="pone.0254826.ref004" ref-type="bibr">4</xref>]. While multiple vaccines against the novel coronavirus have begun to roll out amidst emerging SARS-CoV-2 variants, many scientific uncertainties exist that will dictate how vaccination campaigns will affect the course of the pandemic. For instance, it is still unclear if the vaccine will prevent the transmission of SARS-CoV-2 and its variants or just protect against more severe disease outcomes and death [<xref rid="pone.0254826.ref009" ref-type="bibr">9</xref>–<xref rid="pone.0254826.ref011" ref-type="bibr">11</xref>]. In these circumstances, non-pharmaceutical interventions remain the most promising policy levers to reduce virus transmission [<xref rid="pone.0254826.ref012" ref-type="bibr">12</xref>]. The epidemiological and mathematical models can help quantify the effects of non-pharmaceutical interventions that require behavioral changes such as washing hands, wearing facemasks and social distancing mandates to contain the spread of the virus [<xref rid="pone.0254826.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0254826.ref014" ref-type="bibr">14</xref>]. However, recent studies have demonstrated that population indicators such as poverty, population density, over-crowding, and inappropriate workplace conditions hinder the social distancing interventions propagating the unmitigated spread of the virus, especially in developing countries [<xref rid="pone.0254826.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0254826.ref016" ref-type="bibr">16</xref>]. Moreover, the differential mortality trends are also influenced by the disparate disease burden driven by the socioeconomic gradients with the poorest areas showing the highest preventable mortality rates [<xref rid="pone.0254826.ref017" ref-type="bibr">17</xref>].</p>
              <p>Mexico, exhibiting one of the highest COVID-19 mortality impacts in the world thus far [<xref rid="pone.0254826.ref018" ref-type="bibr">18</xref>], is a highly populated country [<xref rid="pone.0254826.ref019" ref-type="bibr">19</xref>] with ~42% of the population living in poverty (defined as the state of a person or group of people that lack a specified amount of money or material possessions) [<xref rid="pone.0254826.ref020" ref-type="bibr">20</xref>] and ~60% of the population work in the informal sector [<xref rid="pone.0254826.ref021" ref-type="bibr">21</xref>]. A previous study reported an all-cause excess mortality of 26.10 per 10,000 population from March 1, 2020 to January 2, 2021, reflecting a heavy mortality impact of the COVID-19 pandemic in Mexico [<xref rid="pone.0254826.ref022" ref-type="bibr">22</xref>]. In this context, Mexico ranks fourth in the world in terms of the number of COVID-19 deaths, a tally surpassed only by the USA, Brazil, and India [<xref rid="pone.0254826.ref023" ref-type="bibr">23</xref>]. Moreover, the overall lethality of COVID-19 in Mexico has been reported to be 9.2% [<xref rid="pone.0254826.ref024" ref-type="bibr">24</xref>] accompanied by one of the highest death tolls among healthcare workers (~2500 deaths) [<xref rid="pone.0254826.ref025" ref-type="bibr">25</xref>] and the lowest number of COVID-19 tests per capita as of December 29, 2020 [<xref rid="pone.0254826.ref026" ref-type="bibr">26</xref>].</p>
              <p>As the virus infiltrated the country, Mexican Ministry of Health identified three phases of the contingency plan: viral importation, community transmission, and epidemic to combat the COVID-19 pandemic in Mexico [<xref rid="pone.0254826.ref027" ref-type="bibr">27</xref>]. The pandemic in Mexico was likely seeded by imported COVID-19 cases reported by the government on February 28, 2020 [<xref rid="pone.0254826.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0254826.ref028" ref-type="bibr">28</xref>]. As the virus spread across the nation in phase one of the pandemic, some universities switched to virtual classes and some festivals and sporting events were postponed [<xref rid="pone.0254826.ref029" ref-type="bibr">29</xref>]. However, the government initially downplayed the impact of the virus and did not enforce strict social distancing measures [<xref rid="pone.0254826.ref030" ref-type="bibr">30</xref>]. This led to large gatherings at some social events such as concerts, festivals, and soccer tournaments amidst sustained disease transmission in the country [<xref rid="pone.0254826.ref031" ref-type="bibr">31</xref>]. A study conducted in Mexico estimated the early reproduction number for the first ten days of the pandemic between 2.9–4.9 [<xref rid="pone.0254826.ref032" ref-type="bibr">32</xref>]. However, the true impact of the pandemic was generally underestimated by the Mexican government despite active virus transmission in the country [<xref rid="pone.0254826.ref033" ref-type="bibr">33</xref>].</p>
              <p>As local clusters of the disease started to appear in the community, phase 2 (community transmission) of the pandemic was declared on March 24, 2020 [<xref rid="pone.0254826.ref034" ref-type="bibr">34</xref>]. Authorities suspended all non-essential activities including the closure of public and entertainment places and banned gatherings of more than 100 people [<xref rid="pone.0254826.ref034" ref-type="bibr">34</xref>–<xref rid="pone.0254826.ref036" ref-type="bibr">36</xref>]. This was followed by the declaration of a national emergency on March 30, 2020. The new measures to fight the virus under the national emergency included extending the suspension of non-essential activities and a reduction in the number of people who can gather not to exceed fifty [<xref rid="pone.0254826.ref037" ref-type="bibr">37</xref>]. However, as the virus paved its way across the country ravaging the poor and rural communities, the government urged the public to comply with the stay-at-home orders [<xref rid="pone.0254826.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0254826.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0254826.ref039" ref-type="bibr">39</xref>]. These preventive orders from the government were met with mixed reactions from people belonging to different socio-economic sectors of the community [<xref rid="pone.0254826.ref040" ref-type="bibr">40</xref>]. Moreover, transportation restrictions to and from the regions most affected by COVID-19 were not implemented until April 16, 2020 [<xref rid="pone.0254826.ref041" ref-type="bibr">41</xref>]. Shortly after, on April 21, 2020, Mexico announced phase 3 of the contingency (epidemic phase) as widespread community transmission intensified [<xref rid="pone.0254826.ref042" ref-type="bibr">42</xref>].</p>
              <p>With lockdowns and other restrictions in place, Mexican officials shared model output [<xref rid="pone.0254826.ref043" ref-type="bibr">43</xref>] predicting that COVID-19 case counts would peak in early May and that the pandemic was expected to end before July 2020 [<xref rid="pone.0254826.ref044" ref-type="bibr">44</xref>]. Despite notorious disagreement between surveillance data and government forecasts, these model predictions continued to be cited by official and independent sources [<xref rid="pone.0254826.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0254826.ref046" ref-type="bibr">46</xref>]. The extent to which these overly optimistic predictions skewed the plans and budgets of private and public institutions remains unknown. Under the official narrative that the pandemic would soon be over, Mexico planned a gradual phased re-opening of its economy in early June 2020, as the “new normal” phase [<xref rid="pone.0254826.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0254826.ref047" ref-type="bibr">47</xref>].</p>
              <p>In Mexico, the reopening of the economic activities started on June 1 under a four-color traffic light monitoring system to alert the residents of the epidemiological risks of COVID-19 based on the level of severity of the pandemic in each state, on a bi-weekly basis [<xref rid="pone.0254826.ref048" ref-type="bibr">48</xref>]. As of December 29, 2020, Mexico exhibits high estimates of cumulative COVID-19 cases and deaths; 1,401,529 and 123,845 respectively [<xref rid="pone.0254826.ref018" ref-type="bibr">18</xref>]. Given the high transmission potential of the virus and limited application of tests in the country, testing only 24.54 people for every 1000 people (as of December 28, 2020) [<xref rid="pone.0254826.ref026" ref-type="bibr">26</xref>], estimates of the effective reproduction number from the case incidence data and near real-time epidemic projections using mortality data could prove to be highly beneficial to understand the trajectory of the COVID-19 pandemic in Mexico. It may also be useful to assess the effect of mobility patterns and intervention strategies such as the stay-at-home orders on the epidemic curve and understand the different spatiotemporal dynamics of the virus.</p>
              <p>In order to investigate the transmission dynamics of the unfolding COVID-19 pandemic in Mexico, we analyze the case incidence data by date of symptoms onset and mortality data by date of report utilizing mathematical models that are useful to characterize the empirical patterns of epidemics [<xref rid="pone.0254826.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0254826.ref050" ref-type="bibr">50</xref>]. We estimate the effective reproduction number of SARS-CoV-2 in Mexico to understand the transmission dynamics of the virus and examine the mobility trends in relation to the curve of the number of COVID-19 deaths. Moreover, we employ statistical methods from functional data analysis to study the shapes of the COVID-19 growth rate curves at the state level. This helps us characterize the spatiotemporal dynamics of the pandemic based on the shape features of these curves. Lastly, Twitter data corresponding to frequency of tweets indicating stay-at-home-order are analyzed in relation to the COVID-19 case counts at the national level.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Methods</title>
              <sec id="sec003">
                <title>Data</title>
                <p>Five sources of data are analyzed in this manuscript. A brief description of the datasets and their sources is presented below.</p>
                <sec id="sec004">
                  <title>(i) IHME data for short-term forecasts</title>
                  <p>We utilized the openly published smoothed trend in daily COVID-19 reported deaths from the Institute of Health Metrics and Evaluation (IHME) for (i) Mexico (country) and (ii) Mexico City (capital of Mexico) as of October 9, 2020, to generate the sequential forecasts [<xref rid="pone.0254826.ref051" ref-type="bibr">51</xref>]. IHME smoothed death data estimates (current projection scenario) publicly available from the IHME COVID-19 estimates downloads page were analyzed [<xref rid="pone.0254826.ref051" ref-type="bibr">51</xref>]. The death estimates were corrected for the irregularities in the reporting of daily deaths by averaging model results over the last seven days. The statistical procedure of spline regressions obtained from MR-BRT (“meta-regression—Bayesian, regularized, trimmed”) was utilized to smooth the trend in COVID-19 reported deaths as described in the study [<xref rid="pone.0254826.ref012" ref-type="bibr">12</xref>]. This source of data for prediction modeling was chosen for its consistent updates. For this analysis, deaths reported by the IHME model (current projection scenario) on November 11, 2020, were used as a proxy for actual reported deaths attributed to COVID-19.</p>
                </sec>
                <sec id="sec005">
                  <title>(ii) Apple mobility trends data</title>
                  <p>Publicly available mobility data for Mexico, published by Apple’s mobility trends reports was retrieved as of December 5, 2020 [<xref rid="pone.0254826.ref052" ref-type="bibr">52</xref>]. This aggregated and anonymized data is updated daily and includes the relative volume of directions requests per country compared to a baseline volume on January 13, 2020. Apple has released the data for the three modes of human mobility: driving, walking and public transit. The mobility measures are normalized in the range 0–100 for each country at the beginning of the series, so trends are relative to this baseline.</p>
                </sec>
                <sec id="sec006">
                  <title>(iii) Case incidence and genomic data for estimating reproduction number</title>
                  <p>To estimate the reproduction number, we use two different data sources. For estimating the early reproduction number from the genomic data, 111 SARS-CoV-2 genome samples were obtained from the “global initiative on sharing avian influenza data” (GISAID) repository between February 27- May 29, 2020 [<xref rid="pone.0254826.ref053" ref-type="bibr">53</xref>]. For estimating the reproduction number from the case incidence data (early reproduction number and the instantaneous reproduction number), we utilized a publicly available time series of laboratory-confirmed cases by dates of symptoms onset which were obtained from the Mexican Ministry of Health Mexico, as of December 5, 2020 [<xref rid="pone.0254826.ref018" ref-type="bibr">18</xref>].</p>
                </sec>
                <sec id="sec007">
                  <title>(iv) Case incidence data for spatial analysis</title>
                  <p>We recovered daily case incidence data for all 32 states of Mexico from March 20 to December 5 from the Ministry of Health Mexico, as of December 5, 2020 [<xref rid="pone.0254826.ref018" ref-type="bibr">18</xref>].</p>
                </sec>
                <sec id="sec008">
                  <title>(v) Twitter data for Twitter analysis</title>
                  <p>For the Twitter data analysis, we retrieved data from the publicly available Twitter data set of COVID-19 chatter from March 12 to November 11, 2020 [<xref rid="pone.0254826.ref054" ref-type="bibr">54</xref>].</p>
                </sec>
              </sec>
              <sec id="sec009">
                <title>Modeling framework for forecast generation</title>
                <p>We harness three dynamic phenomenological growth models previously applied to multiple infectious diseases (e.g., SARS, foot and mouth disease, Ebola [<xref rid="pone.0254826.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0254826.ref056" ref-type="bibr">56</xref>] and the current COVID-19 outbreak [<xref rid="pone.0254826.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0254826.ref058" ref-type="bibr">58</xref>]) for mortality modeling and short-term forecasting in Mexico and Mexico City. These models include the simple scalar differential equation models such as the generalized logistic growth model [<xref rid="pone.0254826.ref056" ref-type="bibr">56</xref>] and the Richards growth model [<xref rid="pone.0254826.ref059" ref-type="bibr">59</xref>]. We also utilize the sub-epidemic wave model [<xref rid="pone.0254826.ref055" ref-type="bibr">55</xref>] which accommodates complex epidemic trajectories by assembling the contribution of multiple overlapping sub-epidemic waves. The mortality forecasts obtained from these mathematical models can provide valuable insights on the disease transmission mechanisms, the efficacy of intervention strategies and help evaluate optimal resource allocation procedures to inform public health policies. The COVID-19 mortality forecasts for Mexico and Mexico City generated by IHME (current projections scenario) are used as a benchmark model. The description of these models is provided in the <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>.</p>
                <p>Cumulative mortality forecasts obtained from our phenomenological growth models are compared with the total mean smoothed death data estimates retrieved from the IHME reference scenario and two IHME counterfactual scenarios. The IHME reference scenario depicts the “current projection”, which assumes that the social distancing measures are re-imposed for six weeks whenever daily deaths reach eight per million. The second scenario “mandates easing” implies what would happen if the government continued to ease social distancing measures without re-imposition. Lastly, the third scenario, “universal masks” accounts for universal facemask wearing, which reflects 95% facemask usage in public and social distancing mandates reimposed at 8 deaths per million. A detailed description of these modeling scenarios and their assumptions is explained in reference [<xref rid="pone.0254826.ref012" ref-type="bibr">12</xref>]. Moreover, the total mean smoothed death data estimates reported by the IHME reference scenario as of November 11, 2020, are considered as a proxy for the actual death count for each forecasting period.</p>
              </sec>
              <sec id="sec010">
                <title>Model calibration and forecasting approach</title>
                <p>We conducted 30-day ahead short-term forecasts utilizing thirteen data sets spanned over a period of four months (July 4-October 9, 2020) (<xref rid="pone.0254826.t001" ref-type="table">Table 1</xref>). Each forecast was fitted to the daily death counts from the IHME smoothed death data estimates reported between March 20-September 27, 2020 for (i) Mexico and (ii) Mexico City. The first model calibration process relies on fifteen weeks of data, from March 20-July 4, 2020. Sequentially models are recalibrated each week with the most up-to-date data, meaning the length of the calibration period increases by one week up to August 2, 2020. However, owing to the irregular publishing of data estimates by the IHME, the length of the calibration period increased by 2 weeks after August 2, 2020. This was followed by a one-week increase from August 17-September 27, 2020, as the data estimates were again published every week.</p>
                <table-wrap position="float" id="pone.0254826.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Characteristics of the data sets used for the sequential calibration and forecasting of the COVID-19 pandemic in Mexico and Mexico City (2020).</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0254826.t001" id="pone.0254826.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Date of the retrieval of the data set (MMDD)</th>
                          <th align="center" rowspan="1" colspan="1">Calibration period for the GLM, sub-epidemic, Richards and IHME model</th>
                          <th align="center" rowspan="1" colspan="1">Calibration period (number of days)</th>
                          <th align="center" rowspan="1" colspan="1">Forecast period for the GLM, sub-epidemic, Richards and IHME model</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">07/04</td>
                          <td align="center" rowspan="1" colspan="1">03/20-07/04</td>
                          <td align="center" rowspan="1" colspan="1">107</td>
                          <td align="center" rowspan="1" colspan="1">07/05-08/03</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">07/10</td>
                          <td align="center" rowspan="1" colspan="1">03/20-07/11</td>
                          <td align="center" rowspan="1" colspan="1">114</td>
                          <td align="center" rowspan="1" colspan="1">07/12-08/10</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">07/17</td>
                          <td align="center" rowspan="1" colspan="1">03/20-07/17</td>
                          <td align="center" rowspan="1" colspan="1">120</td>
                          <td align="center" rowspan="1" colspan="1">07/18-08/16</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">07/27</td>
                          <td align="center" rowspan="1" colspan="1">03/20-07/25</td>
                          <td align="center" rowspan="1" colspan="1">128</td>
                          <td align="center" rowspan="1" colspan="1">07/26-08/24</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">08/06</td>
                          <td align="center" rowspan="1" colspan="1">03/20-08/02</td>
                          <td align="center" rowspan="1" colspan="1">136</td>
                          <td align="center" rowspan="1" colspan="1">08/03-09/01</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">08/22</td>
                          <td align="center" rowspan="1" colspan="1">03/20-08/17</td>
                          <td align="center" rowspan="1" colspan="1">151</td>
                          <td align="center" rowspan="1" colspan="1">08/18-09/16</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">08/27</td>
                          <td align="center" rowspan="1" colspan="1">03/20-08/22</td>
                          <td align="center" rowspan="1" colspan="1">156</td>
                          <td align="center" rowspan="1" colspan="1">08/23-09/21</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">09/02</td>
                          <td align="center" rowspan="1" colspan="1">03/20-08/30</td>
                          <td align="center" rowspan="1" colspan="1">164</td>
                          <td align="center" rowspan="1" colspan="1">08/31-09/30</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">09/11</td>
                          <td align="center" rowspan="1" colspan="1">03/20-09/07</td>
                          <td align="center" rowspan="1" colspan="1">172</td>
                          <td align="center" rowspan="1" colspan="1">09/08-10/08</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">09/18</td>
                          <td align="center" rowspan="1" colspan="1">03/20-09/13</td>
                          <td align="center" rowspan="1" colspan="1">179</td>
                          <td align="center" rowspan="1" colspan="1">09/14-10/13</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">09/24</td>
                          <td align="center" rowspan="1" colspan="1">03/20-09/20</td>
                          <td align="center" rowspan="1" colspan="1">185</td>
                          <td align="center" rowspan="1" colspan="1">09/21-10/21</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">10/02</td>
                          <td align="center" rowspan="1" colspan="1">03/20-09/27</td>
                          <td align="center" rowspan="1" colspan="1">193</td>
                          <td align="center" rowspan="1" colspan="1">09/28-10/27</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">10/09</td>
                          <td align="center" rowspan="1" colspan="1">03/20-09/27</td>
                          <td align="center" rowspan="1" colspan="1">193</td>
                          <td align="center" rowspan="1" colspan="1">09/28-10/27</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>The 30-day ahead forecasts generated by calibrating our three phenomenological growth models with the IHME smoothed death data estimates are compared with the forecasts generated by the IHME reference scenario for the same calibration and forecasting periods.</p>
                <p>For each of the three models; GLM, Richards growth model, and the sub-epidemic wave model, we estimate the best fit solution for each model using nonlinear least-square fitting procedure [<xref rid="pone.0254826.ref060" ref-type="bibr">60</xref>]. This process yields the best set of parameter estimates <inline-formula id="pone.0254826.e001"><alternatives><graphic xlink:href="pone.0254826.e001.jpg" id="pone.0254826.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mi>Θ</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> by minimizing the sum of squared errors between the model fit, <inline-formula id="pone.0254826.e002"><alternatives><graphic xlink:href="pone.0254826.e002.jpg" id="pone.0254826.e002g" position="anchor"/><mml:math id="M2" display="inline" overflow="scroll"><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> and the smoothed death data estimates, <inline-formula id="pone.0254826.e003"><alternatives><graphic xlink:href="pone.0254826.e003.jpg" id="pone.0254826.e003g" position="anchor"/><mml:math id="M3" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>. The estimated set of parameters <inline-formula id="pone.0254826.e004"><alternatives><graphic xlink:href="pone.0254826.e004.jpg" id="pone.0254826.e004g" position="anchor"/><mml:math id="M4" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula> define the best-fit model <inline-formula id="pone.0254826.e005"><alternatives><graphic xlink:href="pone.0254826.e005.jpg" id="pone.0254826.e005g" position="anchor"/><mml:math id="M5" display="inline" overflow="scroll"><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula>. Here <inline-formula id="pone.0254826.e006"><alternatives><graphic xlink:href="pone.0254826.e006.jpg" id="pone.0254826.e006g" position="anchor"/><mml:math id="M6" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mspace width="0.25em"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> corresponds to the set of parameters of the sub-epidemic model, <inline-formula id="pone.0254826.e007"><alternatives><graphic xlink:href="pone.0254826.e007.jpg" id="pone.0254826.e007g" position="anchor"/><mml:math id="M7" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> corresponds to the set of parameters of the Richards model, and <inline-formula id="pone.0254826.e008"><alternatives><graphic xlink:href="pone.0254826.e008.jpg" id="pone.0254826.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> corresponds to the set of parameters of the GLM model [<xref rid="pone.0254826.ref061" ref-type="bibr">61</xref>]. For the GLM and sub-epidemic wave model, we provide initial best guesses of the parameter estimates. However, for the Richards growth model, we initialize the parameters for the nonlinear least-squares’ method [<xref rid="pone.0254826.ref060" ref-type="bibr">60</xref>] over a wide range of plausible parameters from a uniform distribution using Latin hypercube sampling [<xref rid="pone.0254826.ref062" ref-type="bibr">62</xref>]. This allows us to test the uniqueness of the best fit model. Moreover, the initial conditions are set at the first data point for each of the three models [<xref rid="pone.0254826.ref061" ref-type="bibr">61</xref>]. Uncertainty bounds around the best-fit solution are generated using a parametric bootstrap approach which involves resampling with replacement of data assuming a Poisson error structure for the GLM and sub-epidemic model. A negative binomial error structure is used to generate the uncertainty bounds for the Richards growth model; where we assume the mean to be three times the variance based on the noise in the data. A detailed description of this method is provided in the previous study [<xref rid="pone.0254826.ref061" ref-type="bibr">61</xref>].</p>
                <p>Each of the <italic toggle="yes">M</italic> best-fit parameter sets is used to construct the 95% confidence intervals for each parameter by refitting the models to each of the <italic toggle="yes">M</italic> = 300 datasets generated by the bootstrap approach during the calibration phase. Further, each <italic toggle="yes">M</italic> best-fit model solution is used to generate <italic toggle="yes">m</italic> = 30 additional simulations with Poisson error structure for GLM and sub-epidemic model and negative binomial error structure for Richards model extended through a 30-day forecasting period. For the forecasting period, we construct the 95% prediction intervals with these 9000 (<italic toggle="yes">M × m</italic>) curves. A detailed description of the methods of parameter estimation can be found in prior studies [<xref rid="pone.0254826.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0254826.ref063" ref-type="bibr">63</xref>, <xref rid="pone.0254826.ref064" ref-type="bibr">64</xref>].</p>
              </sec>
              <sec id="sec011">
                <title>Performance metrics</title>
                <p>We utilized the following four performance metrics to assess the quality of our model fit and the 30-day ahead short-term forecasts: the mean absolute error (MAE) [<xref rid="pone.0254826.ref065" ref-type="bibr">65</xref>], the mean squared error (MSE) [<xref rid="pone.0254826.ref066" ref-type="bibr">66</xref>], the coverage of the 95% prediction intervals (95% PI) [<xref rid="pone.0254826.ref066" ref-type="bibr">66</xref>], and the mean interval score (MIS) [<xref rid="pone.0254826.ref066" ref-type="bibr">66</xref>] for each of the three models. For calibration performance, we compare the model fit to the observed smoothed death data estimates fitted to the model, whereas for the performance of forecasts, we compare our forecasts with the smoothed death data estimates (current projections scenario) reported on November 11, 2020, for the time-period of the forecast.</p>
                <p>The MSE and the MAE assess the average deviations of the model fit to the observed death data. The MAE is given by:
<disp-formula id="pone.0254826.e009"><alternatives><graphic xlink:href="pone.0254826.e009.jpg" id="pone.0254826.e009g" position="anchor"/><mml:math id="M9" display="block" overflow="scroll"><mml:mi>M</mml:mi><mml:mi>A</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mo>|</mml:mo><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula></p>
                <p>The MSE is given by:
<disp-formula id="pone.0254826.e010"><alternatives><graphic xlink:href="pone.0254826.e010.jpg" id="pone.0254826.e010g" position="anchor"/><mml:math id="M10" display="block" overflow="scroll"><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mo>(</mml:mo><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>
where <inline-formula id="pone.0254826.e011"><alternatives><graphic xlink:href="pone.0254826.e011.jpg" id="pone.0254826.e011g" position="anchor"/><mml:math id="M11" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> is the time series of reported smoothed death estimates, <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub> is the time stamp and <inline-formula id="pone.0254826.e012"><alternatives><graphic xlink:href="pone.0254826.e012.jpg" id="pone.0254826.e012g" position="anchor"/><mml:math id="M12" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Θ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is the set of model parameters. For the calibration period, <italic toggle="yes">n</italic> equals the number of data points used for calibration, and for the forecasting period, <italic toggle="yes">n =</italic> 30 for the 30-day ahead short-term forecast.</p>
                <p>Moreover, to assess the model uncertainty and performance of the prediction interval coverage, we use the 95% PI and MIS. The prediction interval coverage is defined as the proportion of observations that fall within 95% PI and is calculated as:
<disp-formula id="pone.0254826.e013"><alternatives><graphic xlink:href="pone.0254826.e013.jpg" id="pone.0254826.e013g" position="anchor"/><mml:math id="M13" display="block" overflow="scroll"><mml:mi>P</mml:mi><mml:mi>I</mml:mi><mml:mspace width="0.25em"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi mathvariant="bold-italic">I</mml:mi><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>∩</mml:mo><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>
where <inline-formula id="pone.0254826.e014"><alternatives><graphic xlink:href="pone.0254826.e014.jpg" id="pone.0254826.e014g" position="anchor"/><mml:math id="M14" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> are the smoothed death data estimates, <inline-formula id="pone.0254826.e015"><alternatives><graphic xlink:href="pone.0254826.e015.jpg" id="pone.0254826.e015g" position="anchor"/><mml:math id="M15" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0254826.e016"><alternatives><graphic xlink:href="pone.0254826.e016.jpg" id="pone.0254826.e016g" position="anchor"/><mml:math id="M16" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> are the lower and upper bounds of the 95% prediction intervals, respectively, <italic toggle="yes">n</italic> is the length of the period, and I is an indicator variable that equals 1 if the value of <inline-formula id="pone.0254826.e017"><alternatives><graphic xlink:href="pone.0254826.e017.jpg" id="pone.0254826.e017g" position="anchor"/><mml:math id="M17" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> is in the specified interval and 0 otherwise.</p>
                <p>The MIS addresses the width of the prediction interval as well as the coverage. The MIS is given by:
<disp-formula id="pone.0254826.e018"><alternatives><graphic xlink:href="pone.0254826.e018.jpg" id="pone.0254826.e018g" position="anchor"/><mml:math id="M18" display="block" overflow="scroll"><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>0.05</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mi>I</mml:mi><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>0.05</mml:mn></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mi>I</mml:mi><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>&gt;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:math></alternatives></disp-formula></p>
                <p>In this equation <inline-formula id="pone.0254826.e019"><alternatives><graphic xlink:href="pone.0254826.e019.jpg" id="pone.0254826.e019g" position="anchor"/><mml:math id="M19" display="inline" overflow="scroll"><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, <italic toggle="yes">n</italic> and I are as specified above for PI coverage. Therefore, if the PI coverage is 1, the MIS is the average width of the interval across each time point. For two models that have an equivalent PI coverage, a lower value of MIS indicates narrower intervals [<xref rid="pone.0254826.ref066" ref-type="bibr">66</xref>].</p>
              </sec>
              <sec id="sec012">
                <title>Mobility data analysis</title>
                <p>In order to analyze the time-series data for Mexico from March 20-December 5, 2020 for three modes of mobility; driving, walking, and public transport, we utilize the R code developed by Healy [<xref rid="pone.0254826.ref067" ref-type="bibr">67</xref>]. We analyze the mobility trends to look for any common pattern with the mortality curve of COVID-19. The time series for mobility requests is decomposed into trends, weekly and remainder components. The trend is a locally weighted regression fitted to the data and the remainder is any residual leftover on any given day after the underlying trend and normal daily fluctuations have been accounted for.</p>
              </sec>
              <sec id="sec013">
                <title>Reproduction number</title>
                <p>We estimate the reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, for the early ascending phase of the COVID-19 pandemic in Mexico and the instantaneous reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> throughout the pandemic. Reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, is a key parameter that characterizes the average number of secondary cases generated by a primary case at calendar time <italic toggle="yes">t</italic> during the outbreak. This quantity is critical to identify the intensity and magnitude of public health interventions required to contain a pandemic [<xref rid="pone.0254826.ref068" ref-type="bibr">68</xref>–<xref rid="pone.0254826.ref070" ref-type="bibr">70</xref>]. Estimates of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> indicate if widespread disease transmission continues (<italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>&gt;1) or disease transmission declines (<italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>&lt;1). Therefore, to contain an outbreak, it is vital to maintain <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>&lt;1.</p>
              </sec>
              <sec id="sec014">
                <title>Estimating the reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, from case incidence using generalized growth model (GGM)</title>
                <p>We estimate the reproduction number by calibrating the GGM (as described in the <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>) to the early growth phase of the pandemic (February 27-May 29, 2020) [<xref rid="pone.0254826.ref071" ref-type="bibr">71</xref>]. The generation interval of SARS-CoV-2 is modeled assuming gamma distribution with a mean of 5.2 days and a standard deviation of 1.72 days [<xref rid="pone.0254826.ref072" ref-type="bibr">72</xref>]. We estimate the growth rate parameter <italic toggle="yes">r</italic>, and the deceleration of growth parameter, <italic toggle="yes">p</italic>, as described in the <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>. The GGM model is used to simulate the progression of local incidence cases <italic toggle="yes">I</italic><sub><italic toggle="yes">i</italic></sub> at calendar time <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub>. This is followed by the application of the discretized probability distribution of the generation interval, denoted by <italic toggle="yes">ρ</italic><sub><italic toggle="yes">i</italic></sub>, to the renewal equation to estimate the reproduction number at the time <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub> [<xref rid="pone.0254826.ref073" ref-type="bibr">73</xref>–<xref rid="pone.0254826.ref075" ref-type="bibr">75</xref>]:
<disp-formula id="pone.0254826.e020"><alternatives><graphic xlink:href="pone.0254826.e020.jpg" id="pone.0254826.e020g" position="anchor"/><mml:math id="M20" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula></p>
                <p>The numerator represents the total new cases <italic toggle="yes">I</italic><sub><italic toggle="yes">i</italic></sub> at time <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub>, and the denominator represents the total number of cases that contribute (as primary cases) to generate the new cases <italic toggle="yes">I</italic><sub><italic toggle="yes">i</italic></sub> (as secondary cases) at time <italic toggle="yes">t</italic><sub><italic toggle="yes">i</italic></sub>. This way, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, represents the average number of secondary cases generated by a single case at calendar time <italic toggle="yes">t</italic>. The uncertainty bounds around the curve of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> are derived directly from the uncertainty associated with the parameter estimates (<italic toggle="yes">r</italic>, <italic toggle="yes">p</italic>) obtained from the GGM. We estimate <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> for 300 simulated curves assuming a negative binomial error structure [<xref rid="pone.0254826.ref061" ref-type="bibr">61</xref>].</p>
              </sec>
              <sec id="sec015">
                <title>Instantaneous reproduction number <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, using the Cori method</title>
                <p>The instantaneous reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, is estimated by the ratio of the number of new infections generated at calendar time <italic toggle="yes">t</italic> (<italic toggle="yes">I</italic><sub><italic toggle="yes">t</italic></sub>), to the total infectiousness of infected individuals at time <italic toggle="yes">t</italic> given by <inline-formula id="pone.0254826.e021"><alternatives><graphic xlink:href="pone.0254826.e021.jpg" id="pone.0254826.e021g" position="anchor"/><mml:math id="M21" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> [<xref rid="pone.0254826.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0254826.ref077" ref-type="bibr">77</xref>]. Hence <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> can be written as:
<disp-formula id="pone.0254826.e022"><alternatives><graphic xlink:href="pone.0254826.e022.jpg" id="pone.0254826.e022g" position="anchor"/><mml:math id="M22" display="block" overflow="scroll"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula></p>
                <p>In this equation, <italic toggle="yes">I</italic><sub><italic toggle="yes">t</italic></sub> is the number of new infections on day <italic toggle="yes">t</italic> and <italic toggle="yes">w</italic><sub><italic toggle="yes">s</italic></sub> represents the infectivity function, which is the infectivity profile of the infected individual. This is dependent on the time since infection (<italic toggle="yes">s)</italic>, but is independent of the calendar time (<italic toggle="yes">t</italic>) [<xref rid="pone.0254826.ref078" ref-type="bibr">78</xref>, <xref rid="pone.0254826.ref079" ref-type="bibr">79</xref>].</p>
                <p>The term <inline-formula id="pone.0254826.e023"><alternatives><graphic xlink:href="pone.0254826.e023.jpg" id="pone.0254826.e023g" position="anchor"/><mml:math id="M23" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> describes the sum of infection incidence up to time step <italic toggle="yes">t</italic> − 1, weighted by the infectivity function <italic toggle="yes">w</italic><sub><italic toggle="yes">s</italic></sub>. The distribution of the generation time can be applied to approximate <italic toggle="yes">w</italic><sub><italic toggle="yes">s</italic></sub>, however, since the time of infection is rarely an observed event, it is difficult to measure the distribution of generation time [<xref rid="pone.0254826.ref076" ref-type="bibr">76</xref>]. Therefore, the time of symptom onset is usually used to estimate the distribution of serial interval (SI), which is defined as the time interval between the dates of symptom onset among two successive cases in a disease transmission chain [<xref rid="pone.0254826.ref080" ref-type="bibr">80</xref>].</p>
                <p>The infectiousness of a case is a function of the time since infection, which is proportional to <italic toggle="yes">w</italic><sub><italic toggle="yes">s</italic></sub> if the timing of infection in the primary case is set as time zero of <italic toggle="yes">w</italic><sub><italic toggle="yes">s</italic></sub> and we assume that the generation interval equals the SI. The SI was assumed to follow a gamma distribution with a mean of 5.2 days and a standard deviation of 1.72 days [<xref rid="pone.0254826.ref072" ref-type="bibr">72</xref>]. Analytical estimates of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> were obtained within a Bayesian framework using EpiEstim R package in R language [<xref rid="pone.0254826.ref080" ref-type="bibr">80</xref>]. <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> was estimated at weekly intervals. We reported the median and 95% credible interval (CrI).</p>
              </sec>
              <sec id="sec016">
                <title>Estimating the reproduction number, <italic toggle="yes">R</italic>, from the genomic analysis</title>
                <p>In order to estimate the reproduction number for SARS-CoV-2 between February 27- May 29, 2020 from the genomic data, 111 SARS-CoV-2 genomes sampled from infected patients from Mexico, and their sampling times were obtained from GISAID repository [<xref rid="pone.0254826.ref053" ref-type="bibr">53</xref>]. Short sequences and sequences with a significant number of gaps and non-identified nucleotides were removed, yielding 83 high-quality sequences. For clustering, they were complemented by sequences from other geographical regions, down sampled to n = 4325 representative sequences. We used the sequence subsample from Nextstrain (<ext-link xlink:href="http://www.nextstrain.org/" ext-link-type="uri">www.nextstrain.org</ext-link>) global analysis as of August 15, 2020. These sequences were aligned to the reference genome taken from the literature [<xref rid="pone.0254826.ref081" ref-type="bibr">81</xref>] using MUSCLE [<xref rid="pone.0254826.ref082" ref-type="bibr">82</xref>] and trimmed to the same length of 29772 bp. The maximum likelihood phylogeny has been constructed using RAxML (Randomize Axelerated Maximum Likelihood) [<xref rid="pone.0254826.ref083" ref-type="bibr">83</xref>].</p>
                <p>The largest Mexican cluster that possibly corresponds to within-country transmissions has been identified using hierarchical clustering of sequences. The phylodynamics analysis of that cluster has been carried out using BEAST v1.10.4 (Bayesian Evolutionary Analysis by sampling trees) [<xref rid="pone.0254826.ref084" ref-type="bibr">84</xref>]. We used a strict molecular clock and the tree prior with exponential growth coalescent. Markov Chain Monte Carlo sampling has been run for 10,000,000 iterations, and the parameters were sampled every 1000 iterations. The exponential growth rate <italic toggle="yes">f</italic> estimated by BEAST was used to calculate the reproductive number <italic toggle="yes">R</italic>. For that, we utilized the standard assumption that SARS-CoV-2 generation intervals (times between infection and onward transmission) are gamma-distributed [<xref rid="pone.0254826.ref085" ref-type="bibr">85</xref>]. In that case <italic toggle="yes">R</italic> can be estimated as <inline-formula id="pone.0254826.e024"><alternatives><graphic xlink:href="pone.0254826.e024.jpg" id="pone.0254826.e024g" position="anchor"/><mml:math id="M24" display="inline" overflow="scroll"><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>f</mml:mi><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>, where <italic toggle="yes">μ</italic> and <italic toggle="yes">σ</italic> are the mean and standard deviation of that gamma distribution. Their values were taken from the study [<xref rid="pone.0254826.ref072" ref-type="bibr">72</xref>].</p>
              </sec>
              <sec id="sec017">
                <title>Spatial analysis</title>
                <p>For the shape analysis of incidence rate curves, we followed reference [<xref rid="pone.0254826.ref086" ref-type="bibr">86</xref>] to pre-process the daily cumulative COVID-19 case data at the state level as follows:</p>
                <list list-type="alpha-lower">
                  <list-item>
                    <p>Time differencing: If <italic toggle="yes">f</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>) denotes the given cumulative number of confirmed cases for state <italic toggle="yes">i</italic> on day <italic toggle="yes">t</italic>, then per day growth rate at time <italic toggle="yes">t</italic> is given by <italic toggle="yes">g</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>) = <italic toggle="yes">f</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>)−<italic toggle="yes">f</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>−1).</p>
                  </list-item>
                  <list-item>
                    <p>Smoothing: We then smooth the normalized curves using the smooth function in MATLAB.</p>
                  </list-item>
                  <list-item>
                    <p>Rescaling: Rescaling of each curve is done by dividing each <italic toggle="yes">g</italic><sub><italic toggle="yes">i</italic></sub> by the total confirmed cases for a state <italic toggle="yes">i</italic>. That is, compute <italic toggle="yes">h</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>) = <italic toggle="yes">g</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>)/<italic toggle="yes">r</italic><sub><italic toggle="yes">i</italic></sub>, where <italic toggle="yes">r</italic><sub><italic toggle="yes">i</italic></sub> = ∑<sub><italic toggle="yes">t</italic></sub><italic toggle="yes">g</italic><sub><italic toggle="yes">i</italic></sub>(<italic toggle="yes">t</italic>).</p>
                  </list-item>
                </list>
                <p>This process is depicted in <xref rid="pone.0254826.s018" ref-type="supplementary-material">S17 Fig</xref>. To identify the clusters by comparing the curves, we used a simple metric. For any two rate curves, <italic toggle="yes">h</italic><sub><italic toggle="yes">i</italic></sub> and <italic toggle="yes">h</italic><sub><italic toggle="yes">j</italic></sub>, we compute the norm ||<italic toggle="yes">h</italic><sub><italic toggle="yes">i</italic></sub>−<italic toggle="yes">h</italic><sub><italic toggle="yes">j</italic></sub>||, where the double bars denote the L<sup>2</sup> norm of the difference function, i.e., ||<italic toggle="yes">h</italic><sub><italic toggle="yes">i</italic></sub>−<italic toggle="yes">h</italic><sub><italic toggle="yes">j</italic></sub>|| = <inline-formula id="pone.0254826.e025"><alternatives><graphic xlink:href="pone.0254826.e025.jpg" id="pone.0254826.e025g" position="anchor"/><mml:math id="M25" display="inline" overflow="scroll"><mml:msqrt><mml:msub><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:msqrt></mml:math></alternatives></inline-formula>. To perform clustering of 32 curves into smaller groups, we apply the dendrogram function in Matlab using the “ward” linkage as explained in reference [<xref rid="pone.0254826.ref086" ref-type="bibr">86</xref>]. The number of clusters is decided empirically based on the display of overall clustering results. After clustering the states into different groups, we derived the average curve for each cluster after using a time wrapping algorithm as discussed in prior studies [<xref rid="pone.0254826.ref086" ref-type="bibr">86</xref>, <xref rid="pone.0254826.ref087" ref-type="bibr">87</xref>].</p>
              </sec>
              <sec id="sec018">
                <title>Twitter data analysis</title>
                <p>To observe any relationship between the COVID-19 cases by date of symptoms onset and the frequency of tweets indicating stay-at-home orders we used a public dataset of 698 million tweets of COVID-19 chatter [<xref rid="pone.0254826.ref054" ref-type="bibr">54</xref>]. The frequency of tweets indicating stay-at-home order is used to gauge the compliance of people with the orders of staying at home to avoid the spread of the virus by maintaining social distance. Tweets indicate the magnitude of the people being pro-lockdown and depict how these numbers have dwindled over the course of the pandemic. To get to the plotted data, we removed all retweets and tweets that were not in the Spanish language. We also filtered the tweets by the following hashtags: #quedateencasa, and #trabajardesdecasa, which are two of the most used hashtags when users refer to the COVID-19 pandemic and their engagement with health measures. Lastly, we limited the tweets to the ones that originated from Mexico, via its 2-letter country code: MX. A set of 521,359 unique tweets were gathered from March 12 to November 11, 2020. We then overlay the curve of tweets over the epidemic curve in Mexico to observe any relationship between the shape of the epidemic trajectory and the shape of the curve for the frequency of tweets during the established time period. We also estimate the correlation coefficient between the cases and frequency of tweets.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec019">
              <title>Results</title>
              <p>As of November 11, 2020, Mexico has reported 105,656 deaths whereas Mexico City has reported 15,742 deaths per IHME smoothed death data estimates. <xref rid="pone.0254826.g001" ref-type="fig">Fig 1</xref> (upper panel) shows the daily COVID-19 death curve in Mexico and Mexico City from March 20-November 11, 2020. The mobility trend for Mexico (<xref rid="pone.0254826.g001" ref-type="fig">Fig 1</xref>, lower panel) shows that the human mobility tracked in the form of walking, driving and public transportation declined from the end of March to the beginning of June, corresponding to the implementation of social distancing interventions and the <italic toggle="yes">Jornada Nacional de Sana Distancia</italic> that was put in place between March 23-May 30, 2020 enforcing the suspension of non-essential activities in public, private and social sectors [<xref rid="pone.0254826.ref088" ref-type="bibr">88</xref>]. The driving and walking trends subsequently increased in June with the reopening of the non-essential services. <xref rid="pone.0254826.g001" ref-type="fig">Fig 1</xref> (upper panel) shows that the reopening of the country coincides with the highest levels of daily deaths. These remain at a high level for just over two months (June and July). Then from mid-August, the number of deaths begins to fall, reaching a reduction of nearly 50% by mid-October. However, at the end of October 2020, a new spurt in death counts can be observed.</p>
              <fig position="float" id="pone.0254826.g001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>Upper panel: Epidemic curve for the COVID-19 deaths in Mexico and Mexico City from March 20-November 11, 2020.</title>
                  <p>The blue line depicts the confirmed deaths in Mexico and the green line depicts the confirmed deaths in Mexico City. Lower panel: The mobility trends for Mexico from February 28-December 5, 2020. The orange line shows the driving trend, the blue line shows the transit trend, and the black line shows the walking trend.</p>
                </caption>
                <graphic xlink:href="pone.0254826.g001" position="float"/>
              </fig>
              <p>In the subsequent sections, we first present the results for the short-term forecasting, followed by the estimation of the reproduction numbers. Then we present the results for spatial analysis and Twitter data analysis.</p>
              <sec id="sec020">
                <title>Model calibration and forecasting performance</title>
                <p>Here we compare the calibration and 30-day ahead forecasting performance between March 20- September 27, 2020, and July 5-October 27, 2020 respectively of the three models: the GLM, Richards growth model, and the sub-epidemic wave model for (i) Mexico and (ii) Mexico City. We also compare the results of our cumulative mortality forecasts with the total mean smoothed death data estimates retrieved from the three IHME model scenarios (as explained in the methods section).</p>
              </sec>
              <sec id="sec021">
                <title>Calibration performance</title>
                <p>Across the thirteen sequential model calibration phases for Mexico over a period of seven months (March-September), as provided in S1 Table in <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref> and <xref rid="pone.0254826.g002" ref-type="fig">Fig 2</xref>, the sub-epidemic model outperforms the GLM with lower RMSE estimates for the seven calibration phases 03/20-07/04, 03/20-07/17, 03/20-08/17, 03/20-08/22, 03/20-09/13, 03/20-09/20, 03/20-09/27. The GLM model outperforms the other two models for the remaining six calibration phases in terms of RMSE. The Richards model has substantially higher RMSE (between 10.2–24.9) across all thirteen calibration phases indicating a sub-optimal model fit. The sub-epidemic model also outperforms the other two models in terms of MAE, MIS, and the 95% PI coverage. It has the lowest values for MIS and the highest 95% PI coverage for nine of the thirteen calibration phases (S1 Table in <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>). Moreover, the sub-epidemic model has the lowest MAE for eleven calibration phases. The Richards model shows much higher MIS and lower 95% PI coverage compared to the GLM and sub-epidemic model, pointing towards a sub-optimal model fit.</p>
                <fig position="float" id="pone.0254826.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <p><bold>Calibration performance for each of the thirteen sequential calibration phases for GLM (magenta), Richards (red), and sub-epidemic (blue) model for Mexico.</bold> High 95% PI coverage and lower mean interval score (MIS), root mean square error (RMSE), and mean absolute error (MAE) indicate better performance.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g002" position="float"/>
                </fig>
                <p>For Mexico City, the sub-epidemic model outperforms the other two models in terms of all performance metrics. It has the lowest RMSE for eleven of the thirteen calibration phases followed by the GLM and Richards model. The MAE is also the lowest for the sub-epidemic model for all thirteen calibration phases followed by the GLM and Richards growth model. Further, in terms of MIS, the sub-epidemic model outperforms the Richards and GLM model for nine calibration phases whereas the GLM model outperforms the other two models in the remaining four calibration phases (03/20-07/04, 03/20-07/11, 03/20-07/17, 03/20-08/02). The Richards model has much higher estimates for the MIS compared to the other two models indicating a sub-optimal model fit. The 95% PI coverage across all thirteen calibration phases lies between 91.6–99.4% for the sub-epidemic model, followed by the Richards model (85.9–100%) and the GLM model (53.2–100%) (S2 Table in <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>, <xref rid="pone.0254826.g003" ref-type="fig">Fig 3</xref>).</p>
                <fig position="float" id="pone.0254826.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <p><bold>Calibration performance for each of the thirteen sequential calibration phases for GLM (magenta), Richards (red), and sub-epidemic (blue) model for Mexico City.</bold> High 95% PI coverage and lower mean interval score (MIS), root mean square error (RMSE) and mean absolute error (MAE) indicate better performance.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g003" position="float"/>
                </fig>
                <p>Overall, the goodness of fit metrics points toward the sub-epidemic model as the most appropriate model for the Mexico City and Mexico across all four-performance metrics except for the RMSE for Mexico, where the estimates of the GLM model compete with the sub-epidemic model.</p>
              </sec>
              <sec id="sec022">
                <title>Forecasting performance</title>
                <p>For Mexico, the sub-epidemic model consistently outperforms the GLM and Richards growth model for ten out of the thirteen forecasting phases in terms of RMSE and MAE, eight forecasting phases in terms of MIS and nine forecasting phases in terms of the 95% PI coverage. This is followed by the GLM and the Richards growth model (<xref rid="pone.0254826.g004" ref-type="fig">Fig 4</xref>, S4 Table in <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>).</p>
                <fig position="float" id="pone.0254826.g004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <p><bold>Forecasting period performance metrics for each of the thirteen sequential forecasting phases for GLM (magenta), Richards (red) and sub-epidemic (blue) model for Mexico.</bold> High 95% PI coverage and lower mean interval score (MIS), root mean square error (RMSE) and mean absolute error (MAE) indicate better performance.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g004" position="float"/>
                </fig>
                <p>Similarly, for Mexico City, the sub-epidemic model consistently outperforms the GLM and Richards growth model for ten of the thirteen forecasting phases in terms of RMSE and MAE and eleven forecasting phases in terms of the MIS. Whereas, in terms of 95% PI coverage, forecasting phases 08/31–09/29, 09/08-10/08 and 09/21-10/21 show zero 95% PI coverage across all three models. The sub-epidemic model outperforms the Richards and GLM model in six forecasting phases, with the Richards model performing better than the GLM model for the remaining four forecasting phases in terms of the 95% PI coverage (<xref rid="pone.0254826.g005" ref-type="fig">Fig 5</xref>, S3 Table in <xref rid="pone.0254826.s001" ref-type="supplementary-material">S1 File</xref>).</p>
                <fig position="float" id="pone.0254826.g005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <p><bold>Forecasting period performance metrics for each of the thirteen sequential forecasting phases for GLM (magenta), Richards (red) and sub-epidemic (blue) model for the Mexico City.</bold> High 95% PI coverage and lower mean interval score (MIS), root mean square error (RMSE) and mean absolute error (MAE) indicate better performance.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g005" position="float"/>
                </fig>
              </sec>
              <sec id="sec023">
                <title>Comparison of daily death forecasts</title>
                <p>The thirteen sequentially generated daily death forecasts from GLM and Richards growth model, for Mexico and Mexico City indicate towards a sustained decline in the number of deaths (<xref rid="pone.0254826.s002" ref-type="supplementary-material">S1</xref>–<xref rid="pone.0254826.s005" ref-type="supplementary-material">S4</xref> Figs). However, the IHME model forecasts (retrieved from smoothed death data estimates, current projections scenario) indicate a decline in the number of deaths for the first six forecast periods followed by a stable epidemic trajectory for the last seven forecasts, for Mexico City and Mexico. Unlike the GLM and Richards models, the sub-epidemic model can reproduce the observed stabilization of daily deaths observed after the first six forecast periods for Mexico and the last three forecast periods for Mexico City, as can also be seen with the IHME model (<xref rid="pone.0254826.s006" ref-type="supplementary-material">S5</xref>–<xref rid="pone.0254826.s009" ref-type="supplementary-material">S8</xref> Figs).</p>
              </sec>
              <sec id="sec024">
                <title>Comparison of cumulative mortality forecasts</title>
                <p>The total number of COVID-19 deaths is an important quantity to measure the progression of an epidemic. Here we present the results of the estimated cumulative death counts obtained from our 30-day ahead cumulative forecasts generated using the GLM, Richards and sub-epidemic growth model. We compare these results with the total mean smoothed death data estimates obtained from the three IHME modeling scenarios; current projection, universal masks and mandates easing. The total mean smoothed death data estimates obtained from the IHME current projections scenario as of November 11, 2020, are considered as a proxy for the actual death count for each date that the cumulative forecast is obtained (Figs <xref rid="pone.0254826.g006" ref-type="fig">6</xref> and <xref rid="pone.0254826.g007" ref-type="fig">7</xref>).</p>
                <fig position="float" id="pone.0254826.g006">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g006</object-id>
                  <label>Fig 6</label>
                  <caption>
                    <title>Systematic comparison of six models (GLM, Richards, sub-epidemic model, IHME current projections (IHME C.P), IHME universal masks (IHME U.M) and IHME mandates easing (IHME M.E) to predict the cumulative COVID-19 deaths for Mexico in the thirteen sequential forecasts.</title>
                    <p>The blue circles represent the mean deaths, and the magenta vertical line indicates the 95% PI around the mean death count. The horizontal dashed line represents the actual death count reported by that date as published in the November 11, 2020, IHME estimates file.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g006" position="float"/>
                </fig>
                <fig position="float" id="pone.0254826.g007">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g007</object-id>
                  <label>Fig 7</label>
                  <caption>
                    <title>Systematic comparison of six models (GLM, Richards, sub-epidemic model, IHME current projections (IHME C.P), IHME universal masks (IHME U.M) and IHME mandates easing (IHME M.E) to predict the cumulative COVID-19 deaths for the Mexico City in the thirteen sequential forecasts.</title>
                    <p>The blue circles represent the mean deaths, and the magenta vertical line indicates the 95% PI around the mean death count. The horizontal dashed line represents the actual death count reported by that date as published in the November 11, 2020, IHME estimates file.</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g007" position="float"/>
                </fig>
                <sec id="sec025">
                  <title>Mexico</title>
                  <p>The 30-day ahead cumulative forecast results for the thirteen sequentially generated forecasts for Mexico utilizing GLM, Richards growth model, sub-epidemic wave model, and the IHME model (current projections scenario) are presented in <xref rid="pone.0254826.s010" ref-type="supplementary-material">S9</xref>–<xref rid="pone.0254826.s013" ref-type="supplementary-material">S12</xref> Figs. The cumulative mortality estimates comparison is given in <xref rid="pone.0254826.g006" ref-type="fig">Fig 6</xref>. For the first, second, third, and thirteenth generated forecast the GLM, sub-epidemic model, and the Richards model tend to underestimate the true deaths counts (~50,255, ~54,857, ~58,604, 89,730 deaths respectively), whereas the three IHME forecasting scenarios closely estimate the actual death counts for the first, second, and thirteenth forecasting periods. For the fourth, fifth, and seventh generated forecast the sub-epidemic model and the IHME scenarios most closely approximate the actual death counts (~63,078, ~67,075, ~76,054 deaths respectively). For the sixth generated forecast the GLM model closely approximates the actual death count (~73,911 deaths) whereas for the tenth generated forecast the sub-epidemic model closely approximates the actual deaths (~84,471 deaths). For the eighth, ninth, eleventh, and twelfth generated forecast, GLM, Richards, and sub-epidemic model tend to under-predict the actual death counts with the IHME model underestimating the actual death counts for the eleventh and twelfth generated forecast and overestimating the total death counts for the ninth generated forecast (<xref rid="pone.0254826.t002" ref-type="table">Table 2</xref>).</p>
                  <table-wrap position="float" id="pone.0254826.t002">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0254826.t002</object-id>
                    <label>Table 2</label>
                    <caption>
                      <title>Cumulative mortality estimates obtained from the six models (GLM, Richards model, sub-epidemic model, IHME current projections, IHME universal mask and IHME mandates easing) at the end of each forecasting period for the COVID-19 pandemic in Mexico (2020).</title>
                    </caption>
                    <alternatives>
                      <graphic xlink:href="pone.0254826.t002" id="pone.0254826.t002g" position="float"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="justify" rowspan="1" colspan="1">Forecast Number</th>
                            <th align="left" rowspan="1" colspan="1">Forecast period (MMDD)</th>
                            <th align="justify" rowspan="1" colspan="1">GLM Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Sub-epidemic model Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Richards model Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME current projections Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME universal mask Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME mandates easing Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Actual deaths reported as of Nov 11, 2020</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">1</td>
                            <td align="justify" rowspan="1" colspan="1">07/05-08/03</td>
                            <td align="justify" rowspan="1" colspan="1">48,917 (43,931–54,039</td>
                            <td align="justify" rowspan="1" colspan="1">48,110 (42,939–53,661)</td>
                            <td align="justify" rowspan="1" colspan="1">45,808 (38,808–53,665)</td>
                            <td align="justify" rowspan="1" colspan="1">50,721 (47,410–55,597)</td>
                            <td align="justify" rowspan="1" colspan="1">49,692 (46,500–54,250)</td>
                            <td align="justify" rowspan="1" colspan="1">51,299 (47,893–56,184)</td>
                            <td align="justify" rowspan="1" colspan="1">50,255</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">2</td>
                            <td align="justify" rowspan="1" colspan="1">07/12-08/10</td>
                            <td align="justify" rowspan="1" colspan="1">49,412 (44,517–49,412)</td>
                            <td align="justify" rowspan="1" colspan="1">52,085 (46,973–57,379)</td>
                            <td align="justify" rowspan="1" colspan="1">47,358 (39,836–55,808)</td>
                            <td align="justify" rowspan="1" colspan="1">54,438 (49,269–59,598)</td>
                            <td align="justify" rowspan="1" colspan="1">53,615 (48,634–58,590)</td>
                            <td align="justify" rowspan="1" colspan="1">55,176 (49,609–60,621)</td>
                            <td align="justify" rowspan="1" colspan="1">54,857</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">3</td>
                            <td align="justify" rowspan="1" colspan="1">07/18-08/16</td>
                            <td align="justify" rowspan="1" colspan="1">52,197 (47,059–57,541)</td>
                            <td align="justify" rowspan="1" colspan="1">54,758 (49,600–60,070)</td>
                            <td align="justify" rowspan="1" colspan="1">50,055 (42,161–58,892)</td>
                            <td align="justify" rowspan="1" colspan="1">54,572 (39,989–62,409)</td>
                            <td align="justify" rowspan="1" colspan="1">54,020 (39,989–61,614)</td>
                            <td align="justify" rowspan="1" colspan="1">54,749 (39,989–62,710)</td>
                            <td align="justify" rowspan="1" colspan="1">58,604</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">4</td>
                            <td align="justify" rowspan="1" colspan="1">07/26-08/24</td>
                            <td align="justify" rowspan="1" colspan="1">56,658 (51,208–62,320)</td>
                            <td align="justify" rowspan="1" colspan="1">62,271 (56,644–68,073)</td>
                            <td align="justify" rowspan="1" colspan="1">53,742 (45,332–63,144)</td>
                            <td align="justify" rowspan="1" colspan="1">62,902 (58,094–68,253)</td>
                            <td align="justify" rowspan="1" colspan="1">62,194 (57,516–67,205)</td>
                            <td align="justify" rowspan="1" colspan="1">63,116 (58,285–68,542)</td>
                            <td align="justify" rowspan="1" colspan="1">63,078</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">5</td>
                            <td align="justify" rowspan="1" colspan="1">08/03-09/01</td>
                            <td align="justify" rowspan="1" colspan="1">61,451 (55,655–67,494)</td>
                            <td align="justify" rowspan="1" colspan="1">67,010 (60,988–73,219)</td>
                            <td align="justify" rowspan="1" colspan="1">57,186 (48,270–67,114)</td>
                            <td align="justify" rowspan="1" colspan="1">66,376 (63,705–69,334)</td>
                            <td align="justify" rowspan="1" colspan="1">65,944 (63,308–68,853)</td>
                            <td align="justify" rowspan="1" colspan="1">66,582 (63,865–69,612)</td>
                            <td align="justify" rowspan="1" colspan="1">67,075</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">6</td>
                            <td align="justify" rowspan="1" colspan="1">08/18-09/16</td>
                            <td align="justify" rowspan="1" colspan="1">73,700 (66,996–80,655)</td>
                            <td align="justify" rowspan="1" colspan="1">79,144 (72,306–86,048)</td>
                            <td align="justify" rowspan="1" colspan="1">65,814 (55,834–76,954)</td>
                            <td align="justify" rowspan="1" colspan="1">80,072 (74,140–84,710)</td>
                            <td align="justify" rowspan="1" colspan="1">79,598 (73,772–84,225)</td>
                            <td align="justify" rowspan="1" colspan="1">80,537 (74,479–85,288)</td>
                            <td align="justify" rowspan="1" colspan="1">73,911</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">7</td>
                            <td align="justify" rowspan="1" colspan="1">08/23-09/21</td>
                            <td align="justify" rowspan="1" colspan="1">73,901 (67,126–80,909)</td>
                            <td align="justify" rowspan="1" colspan="1">75,809 (69,107–82,699)</td>
                            <td align="justify" rowspan="1" colspan="1">67,273 (57,061–78,667)</td>
                            <td align="justify" rowspan="1" colspan="1">75,125 (73,161–78,209)</td>
                            <td align="justify" rowspan="1" colspan="1">74,887 (72,993–77,883)</td>
                            <td align="justify" rowspan="1" colspan="1">75,160 (73,207–78,254)</td>
                            <td align="justify" rowspan="1" colspan="1">76,054</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">8</td>
                            <td align="justify" rowspan="1" colspan="1">08/31-09/30</td>
                            <td align="justify" rowspan="1" colspan="1">76,535 (69,509–83,826)</td>
                            <td align="justify" rowspan="1" colspan="1">77,629 (70,688–84,743)</td>
                            <td align="justify" rowspan="1" colspan="1">70,218 (59,490–82,174)</td>
                            <td align="justify" rowspan="1" colspan="1">78,525 (76,644–80,538)</td>
                            <td align="justify" rowspan="1" colspan="1">78,653 (76,767–80,669)</td>
                            <td align="justify" rowspan="1" colspan="1">79,016 (77,057–81,135)</td>
                            <td align="justify" rowspan="1" colspan="1">79,683</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">9</td>
                            <td align="justify" rowspan="1" colspan="1">09/08-10/08</td>
                            <td align="justify" rowspan="1" colspan="1">79,406 (72,084–87,022)</td>
                            <td align="justify" rowspan="1" colspan="1">79,491 (72,250–86,959)</td>
                            <td align="justify" rowspan="1" colspan="1">72,712 (61,556–85,135)</td>
                            <td align="justify" rowspan="1" colspan="1">84,215 (80,639–88,038)</td>
                            <td align="justify" rowspan="1" colspan="1">84,307 (80,682–88,069)</td>
                            <td align="justify" rowspan="1" colspan="1">84,937 (81,130–88,999)</td>
                            <td align="justify" rowspan="1" colspan="1">82,669</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">10</td>
                            <td align="justify" rowspan="1" colspan="1">09/14-10/13</td>
                            <td align="justify" rowspan="1" colspan="1">81,546 (74,030–89,356)</td>
                            <td align="justify" rowspan="1" colspan="1">84,561 (76,905–92,411)</td>
                            <td align="justify" rowspan="1" colspan="1">74,504 (63,026–87,292)</td>
                            <td align="justify" rowspan="1" colspan="1">86,249 (84,255–88,722)</td>
                            <td align="justify" rowspan="1" colspan="1">85,926 (83,982–88,256)</td>
                            <td align="justify" rowspan="1" colspan="1">86,249 (84,259–88,694)</td>
                            <td align="justify" rowspan="1" colspan="1">84,471</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">11</td>
                            <td align="justify" rowspan="1" colspan="1">09/21-10/21</td>
                            <td align="justify" rowspan="1" colspan="1">82,815 (75,098, 90,804)</td>
                            <td align="justify" rowspan="1" colspan="1">84,392 (76,640–92,327)</td>
                            <td align="justify" rowspan="1" colspan="1">76,386 (64,579–89,556)</td>
                            <td align="justify" rowspan="1" colspan="1">84,731 (83,126–86,880)</td>
                            <td align="justify" rowspan="1" colspan="1">84,435 (82,872–86,512)</td>
                            <td align="justify" rowspan="1" colspan="1">84,731 (83,135–86,864)</td>
                            <td align="justify" rowspan="1" colspan="1">87,396</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">12</td>
                            <td align="justify" rowspan="1" colspan="1">09/28-10/27</td>
                            <td align="justify" rowspan="1" colspan="1">84,827 (76,896–93,047)</td>
                            <td align="justify" rowspan="1" colspan="1">85,885 (77,943–94,022)</td>
                            <td align="justify" rowspan="1" colspan="1">78,448 (66,244–92,090)</td>
                            <td align="justify" rowspan="1" colspan="1">87,491 (84,095–90,872)</td>
                            <td align="justify" rowspan="1" colspan="1">87,265 (83,967–90,580</td>
                            <td align="justify" rowspan="1" colspan="1">87,522 (84,115–90,945)</td>
                            <td align="justify" rowspan="1" colspan="1">89,730</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">13</td>
                            <td align="justify" rowspan="1" colspan="1">09/28-10/27</td>
                            <td align="justify" rowspan="1" colspan="1">85,197 (77,258–93,454)</td>
                            <td align="justify" rowspan="1" colspan="1">86,850 (78,896–95,001)</td>
                            <td align="justify" rowspan="1" colspan="1">77,876 (65,750–91,401)</td>
                            <td align="justify" rowspan="1" colspan="1">89,666 (88,264–91,036)</td>
                            <td align="justify" rowspan="1" colspan="1">89,627 (88,280–91036)</td>
                            <td align="justify" rowspan="1" colspan="1">89,667 (88,281–91,036)</td>
                            <td align="justify" rowspan="1" colspan="1">89,730</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                  </table-wrap>
                  <p>In summary, the Richards growth model consistently under-estimates the actual death counts compared to the GLM, sub-epidemic model, and three IHME modeling scenarios. The GLM model also provides lower estimates of mean death counts compared to the sub-epidemic model and the three IHME modeling scenarios, but higher mean death estimates compared to the Richards model. The 95% PI for the Richards model is substantially wider than the other five models indicating greater uncertainty in the results. The actual mean death counts lie within the 95% PI of the sub-epidemic model for all the thirteen forecasts. Moreover, the three IHME modeling scenarios predict approximately similar cumulative death counts across the thirteen generated forecasts, indicating that the three scenarios do not differ substantially.</p>
                </sec>
                <sec id="sec026">
                  <title>Mexico City</title>
                  <p>The 30 day ahead cumulative forecast results for thirteen sequentially generated forecasts for Mexico City utilizing GLM, Richards model, sub-epidemic wave model, and IHME model (current projections scenario) are presented in <xref rid="pone.0254826.s014" ref-type="supplementary-material">S13</xref>–<xref rid="pone.0254826.s017" ref-type="supplementary-material">S16</xref> Figs. The cumulative death comparison is given in <xref rid="pone.0254826.g007" ref-type="fig">Fig 7</xref> and <xref rid="pone.0254826.t003" ref-type="table">Table 3</xref>. For the first generated forecast, the sub-epidemic model closely approximates the actual death count (~10,081 deaths). For the second generated forecast, the sub-epidemic model and the IHME scenarios closely approximate the actual death count (~10,496 deaths). For the third and sixth generated forecast, GLM and Richards model underestimate the actual death count (~10,859, ~12,615 deaths respectively) whereas the sub-epidemic model closely estimates the actual death count for the third forecast and under-predicts the actual death count for the sixth forecast. The three IHME model scenarios seem to predict the actual death counts closely. For the fourth, fifth, and seventh to thirteenth generated forecasts all models under-predict the actual death counts.</p>
                  <table-wrap position="float" id="pone.0254826.t003">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0254826.t003</object-id>
                    <label>Table 3</label>
                    <caption>
                      <title>Cumulative mortality estimates obtained from the six models (GLM, Richards model, sub-epidemic model, IHME current projections, IHME universal mask, and IHME mandates easing) at the end of each forecasting period for the COVID-19 pandemic in Mexico City (2020).</title>
                    </caption>
                    <alternatives>
                      <graphic xlink:href="pone.0254826.t003" id="pone.0254826.t003g" position="float"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="justify" rowspan="1" colspan="1">Forecast Number</th>
                            <th align="justify" rowspan="1" colspan="1">Forecast period (MMDD)</th>
                            <th align="justify" rowspan="1" colspan="1">GLM Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Sub-epidemic model Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Richards model Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME current projections Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME universal mask Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">IHME mandates easing Mean (95% PI)</th>
                            <th align="justify" rowspan="1" colspan="1">Actual deaths reported as of Nov 11, 2020</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">1</td>
                            <td align="justify" rowspan="1" colspan="1">07/05-08/03</td>
                            <td align="justify" rowspan="1" colspan="1">8,480 (6,642–10,549)</td>
                            <td align="justify" rowspan="1" colspan="1">9,655 (7,437–12,016)</td>
                            <td align="justify" rowspan="1" colspan="1">8,628 (5,712–12,363)</td>
                            <td align="justify" rowspan="1" colspan="1">9,075 (8,334–9,888)</td>
                            <td align="justify" rowspan="1" colspan="1">8,991 (8,334–9,888)</td>
                            <td align="justify" rowspan="1" colspan="1">9,195 (8,443–10,182)</td>
                            <td align="justify" rowspan="1" colspan="1">10,081</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">2</td>
                            <td align="justify" rowspan="1" colspan="1">07/12-08/10</td>
                            <td align="justify" rowspan="1" colspan="1">8,968 (7,022–11,119)</td>
                            <td align="justify" rowspan="1" colspan="1">10,534 (8,063–13,187)</td>
                            <td align="justify" rowspan="1" colspan="1">9,015 (5,951–12,971)</td>
                            <td align="justify" rowspan="1" colspan="1">10,091 (8,607–12,421)</td>
                            <td align="justify" rowspan="1" colspan="1">10,018 (8,598–12,263)</td>
                            <td align="justify" rowspan="1" colspan="1">10,254 (8,648–12,905)</td>
                            <td align="justify" rowspan="1" colspan="1">10,496</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">3</td>
                            <td align="justify" rowspan="1" colspan="1">07/18-08/16</td>
                            <td align="justify" rowspan="1" colspan="1">9,447 (7,402–11,710)</td>
                            <td align="justify" rowspan="1" colspan="1">11,287 (8,541–14,037)</td>
                            <td align="justify" rowspan="1" colspan="1">9,495 (6,291–13,616)</td>
                            <td align="justify" rowspan="1" colspan="1">10,388 (8,382–12,505)</td>
                            <td align="justify" rowspan="1" colspan="1">10,323 (8,381–12,365)</td>
                            <td align="justify" rowspan="1" colspan="1">10,467 (8,381–12,660)</td>
                            <td align="justify" rowspan="1" colspan="1">10,859</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">4</td>
                            <td align="justify" rowspan="1" colspan="1">07/26-08/24</td>
                            <td align="justify" rowspan="1" colspan="1">9,588 (7,478–11,891)</td>
                            <td align="justify" rowspan="1" colspan="1">10,249 (8,042–12,622)</td>
                            <td align="justify" rowspan="1" colspan="1">9,575 (6,283–13,836)</td>
                            <td align="justify" rowspan="1" colspan="1">10,481 (9,761–11,551)</td>
                            <td align="justify" rowspan="1" colspan="1">10,424 (9,729–11,433)</td>
                            <td align="justify" rowspan="1" colspan="1">10,526 (9,791–11,623)</td>
                            <td align="justify" rowspan="1" colspan="1">11,326</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">5</td>
                            <td align="justify" rowspan="1" colspan="1">08/03-09/01</td>
                            <td align="justify" rowspan="1" colspan="1">9,786 (7,621–12,166)</td>
                            <td align="justify" rowspan="1" colspan="1">10,232 (7,950–12,686)</td>
                            <td align="justify" rowspan="1" colspan="1">9,737 (6,351–14,140)</td>
                            <td align="justify" rowspan="1" colspan="1">10,314 (9,746–11,477)</td>
                            <td align="justify" rowspan="1" colspan="1">10,290 (9,733–11,423)</td>
                            <td align="justify" rowspan="1" colspan="1">10,314 (9,746–11,477)</td>
                            <td align="justify" rowspan="1" colspan="1">11,769</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">6</td>
                            <td align="justify" rowspan="1" colspan="1">08/18-09/16</td>
                            <td align="justify" rowspan="1" colspan="1">10,388 (8,054–12,957)</td>
                            <td align="justify" rowspan="1" colspan="1">11,103 (8,646–13,752)</td>
                            <td align="justify" rowspan="1" colspan="1">10,425 (6,762–15,212)</td>
                            <td align="justify" rowspan="1" colspan="1">12,099 (11,387–13,118)</td>
                            <td align="justify" rowspan="1" colspan="1">12,055 (11,362–13,046)</td>
                            <td align="justify" rowspan="1" colspan="1">12,184 (11,422–13,255)</td>
                            <td align="justify" rowspan="1" colspan="1">12,615</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">7</td>
                            <td align="justify" rowspan="1" colspan="1">08/23-09/21</td>
                            <td align="justify" rowspan="1" colspan="1">10,615 (8,226–13,272)</td>
                            <td align="justify" rowspan="1" colspan="1">11,205 (8,700–13,911)</td>
                            <td align="justify" rowspan="1" colspan="1">10,411 (6,719–15,250)</td>
                            <td align="justify" rowspan="1" colspan="1">11,826 (11,289–12,584)</td>
                            <td align="justify" rowspan="1" colspan="1">11,794 (11,273–12,527)</td>
                            <td align="justify" rowspan="1" colspan="1">11,826 (11,290–12,585)</td>
                            <td align="justify" rowspan="1" colspan="1">12,966</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">8</td>
                            <td align="justify" rowspan="1" colspan="1">08/31-09/30</td>
                            <td align="justify" rowspan="1" colspan="1">10,851 (8,381–13,581)</td>
                            <td align="justify" rowspan="1" colspan="1">11,103 (8,646–13,752)</td>
                            <td align="justify" rowspan="1" colspan="1">10,872 (6,997–15,950)</td>
                            <td align="justify" rowspan="1" colspan="1">11,829 (11,397–12,328)</td>
                            <td align="justify" rowspan="1" colspan="1">11,842 (11,409–12,527)</td>
                            <td align="justify" rowspan="1" colspan="1">11,871 (11,421–12,394)</td>
                            <td align="justify" rowspan="1" colspan="1">13,414</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">9</td>
                            <td align="justify" rowspan="1" colspan="1">09/08-10/08</td>
                            <td align="justify" rowspan="1" colspan="1">11,182 (8,621–14,011)</td>
                            <td align="justify" rowspan="1" colspan="1">11,237 (8,721–13,955)</td>
                            <td align="justify" rowspan="1" colspan="1">10,820 (6,936–15,966)</td>
                            <td align="justify" rowspan="1" colspan="1">12,547 (11,851–13,318)</td>
                            <td align="justify" rowspan="1" colspan="1">12,560 (11,859–13,340)</td>
                            <td align="justify" rowspan="1" colspan="1">12,604 (11,881–13,413)</td>
                            <td align="justify" rowspan="1" colspan="1">13,838</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">10</td>
                            <td align="justify" rowspan="1" colspan="1">09/14-10/13</td>
                            <td align="justify" rowspan="1" colspan="1">11,553 (8,887–14,492)</td>
                            <td align="justify" rowspan="1" colspan="1">12,443 (9,645–15,439)</td>
                            <td align="justify" rowspan="1" colspan="1">11,064 (7,043–16,373)</td>
                            <td align="justify" rowspan="1" colspan="1">13,256 (12,586–14,106)</td>
                            <td align="justify" rowspan="1" colspan="1">13,215 (12,566–14,031)</td>
                            <td align="justify" rowspan="1" colspan="1">13,256 (12,857–14,105)</td>
                            <td align="justify" rowspan="1" colspan="1">14,107</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">11</td>
                            <td align="justify" rowspan="1" colspan="1">09/21-10/21</td>
                            <td align="justify" rowspan="1" colspan="1">11,711 (8,985–14,714)</td>
                            <td align="justify" rowspan="1" colspan="1">12,636 (9,737–15,742)</td>
                            <td align="justify" rowspan="1" colspan="1">11,811 (7,578–17,367)</td>
                            <td align="justify" rowspan="1" colspan="1">12,727 (12,326–13,200)</td>
                            <td align="justify" rowspan="1" colspan="1">12,699 (12,310, 13,156)</td>
                            <td align="justify" rowspan="1" colspan="1">12,728 (12,327–13,192)</td>
                            <td align="justify" rowspan="1" colspan="1">14,561</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">12</td>
                            <td align="justify" rowspan="1" colspan="1">09/28-10/27</td>
                            <td align="justify" rowspan="1" colspan="1">12,074 (9,253–15,195)</td>
                            <td align="justify" rowspan="1" colspan="1">12,878 (9,919–16,054)</td>
                            <td align="justify" rowspan="1" colspan="1">11,503 (7,315–17,079)</td>
                            <td align="justify" rowspan="1" colspan="1">13,358 (12,718–14,095)</td>
                            <td align="justify" rowspan="1" colspan="1">13,332 (12,705–14,049)</td>
                            <td align="justify" rowspan="1" colspan="1">13,361 (12,720–14,153)</td>
                            <td align="justify" rowspan="1" colspan="1">14,911</td>
                          </tr>
                          <tr>
                            <td align="justify" rowspan="1" colspan="1">13</td>
                            <td align="justify" rowspan="1" colspan="1">09/28-10/27</td>
                            <td align="justify" rowspan="1" colspan="1">12,493 (9,570–15,716)</td>
                            <td align="justify" rowspan="1" colspan="1">13,460 (10,341–16,815)</td>
                            <td align="justify" rowspan="1" colspan="1">11,659 (7,398–17,370)</td>
                            <td align="justify" rowspan="1" colspan="1">14,172 (13,539–15,031)</td>
                            <td align="justify" rowspan="1" colspan="1">14,131 (13,522–14,958)</td>
                            <td align="justify" rowspan="1" colspan="1">14,191 (14,541–15,128)</td>
                            <td align="justify" rowspan="1" colspan="1">15,306</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                  </table-wrap>
                  <p>In general, the Richards growth model has a much wider 95% PI coverage compared to the other models indicating greater uncertainty in the results. The mean cumulative death count estimates for the GLM and Richards model closely approximate each other. However, the actual mean death counts lie within the 95% PI of the GLM and sub-epidemic model for all thirteen forecasts. The three IHME model scenarios predict approximately similar cumulative death counts across the thirteen generated forecasts with much narrow 95% PI’s, indicating that the three scenarios do not differ substantially.</p>
                </sec>
              </sec>
              <sec id="sec027">
                <title>Reproduction number</title>
                <sec id="sec028">
                  <title>Estimate of reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> from case incidence data</title>
                  <p>The reproduction number from the case incidence data (February 27- May 29, 2020) using GGM was estimated at <bold><italic toggle="yes">R</italic></bold><sub><bold><italic toggle="yes">t</italic></bold></sub>~1.1(95% CI: [1.1,1.1]). The growth rate parameter, <italic toggle="yes">r</italic>, was estimated at 1.2 (95% CI: [1.1, 1.4]) and the deceleration of growth parameter, <italic toggle="yes">p</italic>, was estimated at 0.7 (95% CI: [0.68,0.71]) indicating early sub-exponential growth dynamics of the pandemic (<xref rid="pone.0254826.g008" ref-type="fig">Fig 8</xref>).</p>
                  <fig position="float" id="pone.0254826.g008">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g008</object-id>
                    <label>Fig 8</label>
                    <caption>
                      <title>Upper panel: Reproduction number with 95% CI estimated using the GGM model.</title>
                      <p>The estimated reproduction number of the COVID-19 pandemic in Mexico as of May 29, 2020, is 1.1 (95% CI: [1.1, 1.1]). The growth rate parameter, <italic toggle="yes">r</italic>, is estimated at 1.2 (95% CI: [1.1, 1.4]) and the deceleration of growth parameter, <italic toggle="yes">p</italic>, is estimated at 0.7 (95% CI: [0.68, 0.71]). Lower panel: The lower panel shows the GGM fit to the case incidence data for the first 90 days.</p>
                    </caption>
                    <graphic xlink:href="pone.0254826.g008" position="float"/>
                  </fig>
                </sec>
                <sec id="sec029">
                  <title>Estimate of instantaneous reproduction number, R<sub>t</sub></title>
                  <p>The instantaneous reproduction number for Mexico remained consistently above 1.0 until the end of May 2020, after which the reproduction number has fluctuated around 1.0 with the estimate of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>~0.93 (95% CrI: [0.91, 0.94]) as of September 27, 2020. For Mexico City, the reproduction number remained above 1.0 until the end of June after which it has fluctuated around 1.0 with the estimate of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>~0.96 (95% CrI: [0.93, 0.99]) as of September 27, 2020 (<xref rid="pone.0254826.g009" ref-type="fig">Fig 9</xref>).</p>
                  <fig position="float" id="pone.0254826.g009">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g009</object-id>
                    <label>Fig 9</label>
                    <caption>
                      <p>Upper panel: Epidemiological curve (by the dates of symptom onset) for Mexico (left panel) and Mexico City (right panel) as of September 27, 2020. Lower panel: Instantaneous reproduction number with 95% credible intervals for the COVID-19 pandemic in Mexico as of September 27, 2020. The red solid line represents the mean reproduction number for Mexico and the red shaded area represents the 95% credible interval around it. The blue solid line represents the mean reproduction number for Mexico City and the blue shaded region represents the 95% credible interval around it.</p>
                    </caption>
                    <graphic xlink:href="pone.0254826.g009" position="float"/>
                  </fig>
                </sec>
                <sec id="sec030">
                  <title>Estimate of reproduction number, R from genomic data analysis</title>
                  <p>The majority of analyzed Mexican SARS-CoV-2 sequences (69 out of 83) have been sampled in March and April 2020. These sequences are spread along the whole global SARS-CoV-2 phylogeny (<xref rid="pone.0254826.g010" ref-type="fig">Fig 10</xref>) and split into multiple clusters. This indicates multiple introductions of SARS-CoV-2 to the country during the initial pandemic stage (February 27- May 29, 2020). For the largest cluster of size 42, the reproduction number was estimated at <italic toggle="yes">R</italic> = 1.3 (95% HDP (Highest Posterior Density) interval [1.1,1.5]) in accordance with the early estimate of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> obtained from the case incidence data.</p>
                  <fig position="float" id="pone.0254826.g010">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g010</object-id>
                    <label>Fig 10</label>
                    <caption>
                      <title>Global ML tree for SARS-CoV-2 genomic data from February 27- May 29, 2020.</title>
                      <p>Sequences sampled in Mexico are highlighted in red.</p>
                    </caption>
                    <graphic xlink:href="pone.0254826.g010" position="float"/>
                  </fig>
                </sec>
              </sec>
              <sec id="sec031">
                <title>Spatial analysis</title>
                <p>The results from pre-processing of COVID-19 data into growth rate functions are shown in <xref rid="pone.0254826.s018" ref-type="supplementary-material">S17 Fig</xref>. The dendrogram plot shown in <xref rid="pone.0254826.s019" ref-type="supplementary-material">S18 Fig</xref> presents the results of clustering and the states are color coded based on their cluster membership within the map of Mexico (<xref rid="pone.0254826.g011" ref-type="fig">Fig 11</xref>; left panel). The four predominant clusters that were identified include the following states:</p>
                <list list-type="simple">
                  <list-item>
                    <p>Cluster 1: Baja California, Coahuila, Colima, Mexico City, Guanajuato, Guerrero, Hidalgo, Jalisco, Mexico, Michoacán, Morelos, Nuevo Leon, Oaxaca, Puebla, San Luis Potosi, Sinaloa, and Tlaxcala</p>
                  </list-item>
                  <list-item>
                    <p>Cluster 2: Baja California Sur, Campeche, Chiapas, Nayarit, Quintana Roo, Sonora, Tabasco, Tamaulipas, Veracruz, and Yucatan</p>
                  </list-item>
                  <list-item>
                    <p>Cluster 3: Chihuahua</p>
                  </list-item>
                  <list-item>
                    <p>Cluster 4: Aguascalientes, Durango, Queretaro, and Zacatecas</p>
                  </list-item>
                </list>
                <fig position="float" id="pone.0254826.g011">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g011</object-id>
                  <label>Fig 11</label>
                  <caption>
                    <title>Clusters of states by their growth rates.</title>
                    <p>Cluster 1 in blue, cluster 2 in orange, cluster 3 in yellow, and cluster 4 in purple. The right panel shows the average growth rate curves for each cluster (solid curves) and their overall average (black broken curve).</p>
                  </caption>
                  <graphic xlink:href="pone.0254826.g011" position="float"/>
                </fig>
                <p><xref rid="pone.0254826.g011" ref-type="fig">Fig 11</xref> (right panel) shows the average shape of growth rate curves in each cluster and the overall cluster average. <xref rid="pone.0254826.s020" ref-type="supplementary-material">S19 Fig</xref> shows mean growth rate curves and one standard-deviation bands around it in each cluster. Since cluster 3 included only one state, the average growth rate curves of cluster 1, cluster 2, and cluster 4 are shown. The average growth patterns in the three categories are very distinct and clearly visible. For cluster 1, the rate rises rapidly from April to July and then shows small fluctuations. For cluster 2, there is a rapid increase in growth rate from April to July followed by a rapid decline. Chihuahua in cluster 3 shows a slow growth rate until September followed by a rapid rise until mid-September which then declines rapidly. For cluster 4, the rate rises slowly, from April to September, and then shows a rapid rise (<xref rid="pone.0254826.s021" ref-type="supplementary-material">S20 Fig</xref>).</p>
                <p>From the colormap (<xref rid="pone.0254826.g012" ref-type="fig">Fig 12</xref>) we can see that the cases were concentrated from the beginning in the central region in Mexico and Mexico City. Daily cases have been square root transformed to reduce variability in the amplitude of the time series while dashed lines separate the Northern, Central, and Southern regions. <xref rid="pone.0254826.s021" ref-type="supplementary-material">S20 Fig</xref> shows the time-series graph of daily COVID-19 new cases by the date for all states, Northern states, Central states, and the Southern states. As observed for both Northern and Central regions including the national level, the epidemic peaked in mid-July followed by a decline at around mid-September, which then started rising again. Southern states exhibit a stable decline. <xref rid="pone.0254826.s022" ref-type="supplementary-material">S21 Fig</xref> shows the total number of COVID-19 cases at the state level as of December 5, 2020. Some of the areas with a higher concentration of COVID-19 cases are Mexico City, Mexico state, Guanajuato in the central region and, Nuevo Leon in the Northern region.</p>
                <fig position="float" id="pone.0254826.g012">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0254826.g012</object-id>
                  <label>Fig 12</label>
                  <caption>
                    <title>Color scale image of daily COVID-19 cases by region.</title>
                  </caption>
                  <graphic xlink:href="pone.0254826.g012" position="float"/>
                </fig>
              </sec>
              <sec id="sec032">
                <title>Twitter data analysis</title>
                <p>The epidemic curve for Mexico is overlaid with the curve of tweets indicating stay-at-home orders in Mexico as shown in <xref rid="pone.0254826.s023" ref-type="supplementary-material">S22 Fig</xref>. The engagement of people in Mexico with the #quedateencasa hashtag (stay-at-home order hashtag) has been gradually declining as the number of cases has continued to increase or remain at a steady pace, showing the frustration and apathy of the public on lock downs and restrictions. Mostly the non-government public health experts are calling for more lockdowns or continued social distancing measures (without being heard by the authorities). It could also imply that the population is not following the government’s stay-at-home orders and hence we continue to observe the cases. <xref rid="pone.0254826.s023" ref-type="supplementary-material">S22 Fig</xref> shows that the highest number of tweets were made during the earlier part of the pandemic, with the number of tweets declining as of mid-May 2020. In contrast, the number of cases by onset dates peaked around mid-June. The correlation coefficient between the epidemic curve of cases by dates of onset and the curve of tweets representing the stay-at-home orders was estimated at R = -0.001 from March 12- November 11, 2020.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec033">
              <title>Discussion</title>
              <p>We report initial sub-exponential growth dynamics of the COVID-19 pandemic in Mexico and Mexico City with the deceleration of growth parameter, <italic toggle="yes">p</italic>, estimated between 0.6–0.8 from the case incidence and mortality data. Yet, the early estimates of reproduction number, <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>, demonstrate the sustained disease transmission in the country. As <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> fluctuates around 1.0 since the end of July 2020, variable epidemic growth patterns can be observed at the national and state level. As the virus transmission continues in Mexico, Twitter analysis implies the relaxation of lockdowns with inconsequential decline in the mobility patterns observed over the last few weeks as evident from Apple’s mobility trends. Moreover, the systematic comparison of our models across thirteen sequential forecasts suggests that the sub-epidemic model is the most appropriate model for mortality forecasting. The sub-epidemic model can reproduce the stabilization in the trajectory of mortality forecasts as predicted by the IHME model.</p>
              <p>The sub-exponential growth pattern of the COVID-19 pandemic in Mexico can be attributed to a myriad of factors including non-homogenous mixing, spatial structure, population mobility, behavior changes, and control interventions [<xref rid="pone.0254826.ref089" ref-type="bibr">89</xref>]. Our results are consistent with the sub-exponential growth patterns of COVID-19 outbreaks observed in Mexico [<xref rid="pone.0254826.ref090" ref-type="bibr">90</xref>] and Chile [<xref rid="pone.0254826.ref091" ref-type="bibr">91</xref>]. Along with the observed sub-exponential growth dynamics of the COVID-19 pandemic in Mexico, the reproduction number estimated from the genomic sequence analysis and the case incidence data (<italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>~ 1.1–1.2) indicate a sustained transmission of SARS-CoV-2 in Mexico during the early transmission phase of the virus (February 27- May 29, 2020). Our estimates of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> are similar to the estimates of reproduction numbers retrieved from other studies conducted in Mexico [<xref rid="pone.0254826.ref092" ref-type="bibr">92</xref>], Chile [<xref rid="pone.0254826.ref091" ref-type="bibr">91</xref>, <xref rid="pone.0254826.ref093" ref-type="bibr">93</xref>], Peru [<xref rid="pone.0254826.ref094" ref-type="bibr">94</xref>], and Brazil [<xref rid="pone.0254826.ref095" ref-type="bibr">95</xref>]. The early estimate of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> obtained from the Cori <italic toggle="yes">et al</italic>. method (instantaneous reproduction number) in our study also coincides with the early estimates of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> obtained from the case incidence data and the genomic data (<italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub>~1). The instantaneous reproduction number estimated from our study shows that <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> is slightly above 1 since the end of March 2020, without a significant increase. This is in accordance with the estimates of <italic toggle="yes">R</italic><sub><italic toggle="yes">t</italic></sub> obtained from another study conducted in Mexico [<xref rid="pone.0254826.ref014" ref-type="bibr">14</xref>].</p>
              <p>In general, Mexico has observed a sustained SARS-CoV-2 transmission and an increasing or sustained case load despite the implementation of social distancing interventions including the stay-at-home orders that were eased around June 2020. As our Twitter data analysis also shows, the number of cases by onset dates was negatively correlated to the stay-at-home orders. A possible explanation indicates that people might have stopped following the government’s preventive orders to stay at home as a result of pandemic fatigue [<xref rid="pone.0254826.ref096" ref-type="bibr">96</xref>, <xref rid="pone.0254826.ref097" ref-type="bibr">97</xref>]. Mexico has been one of the countries where the stay-at-home orders have been least respected. The average reduction in mobility in Mexico was reported to be 80% by mid-April that has declined to ~34% since August 2020. In comparison, Argentina and Peru have showed the largest mobility reductions ranging from 60–90% between March-September 2020 [<xref rid="pone.0254826.ref098" ref-type="bibr">98</xref>]. The preventive orders have affected the Mexican population disproportionately, with some proportion of the population exhibiting aggression towards quarantine and stay-at-home orders [<xref rid="pone.0254826.ref040" ref-type="bibr">40</xref>]. However, the public health professionals seem to be frustrated towards the relaxation of stay-at-home orders and reopening of the country, as the cases and deaths keep mounting. We can also appreciate the variable spatiotemporal dynamics of the COVID-19 pandemic in Mexico. Our classification of the epidemic patterns at the state level in Mexico shows a distinct variation of growth rates across states. For instance, cluster 1 including Baja California, Colima, and Mexico City has stable growth at a higher rate and cluster 4 including Aguascalientes, Durango, Queretaro, and Zacatecas shows a rising pattern in the growth rate (<xref rid="pone.0254826.g011" ref-type="fig">Fig 11</xref>). Hence, the place of residence of an individual can largely influence their vulnerability during an epidemic [<xref rid="pone.0254826.ref099" ref-type="bibr">99</xref>]. This information can be utilized by the states in guiding their decision regarding the implementation of public health measures. For example, states in clusters 1 and 4 may need strict public health measures to contain the pandemic.</p>
              <p>Appropriate short-term forecasts can also help gauge the impact of interventions in near real-time. In this study, we compared the performance of our three models for short-term real-time forecasting the COVID-19 mortality estimates in Mexico and Mexico City. As in Figs <xref rid="pone.0254826.g002" ref-type="fig">2</xref>–<xref rid="pone.0254826.g005" ref-type="fig">5</xref>, the sub-epidemic model can be declared the most appropriate model as it exhibits the most desirable performance metrics across most of the calibration and forecasting phases. This model has the capacity to accommodate more complex epidemic trajectories suggesting a longer epidemic wave and can better adjust to the early signs of changes in disease transmission, while other models (GLM and Richards) are less reactive. This model can also be utilized as a potential forecasting tool for other cities in Mexico and be compared with other prediction models. Further short-term forecasts (5,10 days) could be also be conducted with the sub-epidemic model using the consecutive calibration phases to reduce the error metrics [<xref rid="pone.0254826.ref055" ref-type="bibr">55</xref>].</p>
              <p>Overall, the sequential forecasts based on the daily smoothed death estimates for Mexico from the two models (GLM and Richards growth model) suggest a decline in overall deaths (<xref rid="pone.0254826.s002" ref-type="supplementary-material">S1</xref> and <xref rid="pone.0254826.s003" ref-type="supplementary-material">S2</xref> Figs) consistent with the sustained decline in COVID-19 associated case fatalities since mid-August as reported officially by the government of Mexico [<xref rid="pone.0254826.ref100" ref-type="bibr">100</xref>]. However, this decline in COVID-19 deaths can be attributed to the inaccurate reporting of deaths in the surveillance system or downplay of fatalities by the government. For instance, the reported excess deaths as of September 26, 2020, are estimated to be 193,170 with 139,151 deaths attributable to COVID-19 [<xref rid="pone.0254826.ref101" ref-type="bibr">101</xref>]. While the official tally of COVID-19 deaths in Mexico is only exceeded by the USA and Brazil, it is roughly the same as that of India, a country whose population is ten times larger than Mexico [<xref rid="pone.0254826.ref102" ref-type="bibr">102</xref>]. As observed earlier, the easing of the social distancing interventions and lifting of lockdowns in Mexico in the month of June led to a surge of the COVID-19 associated deaths [<xref rid="pone.0254826.ref103" ref-type="bibr">103</xref>]. In June, the government of Mexico also inaccurately forecasted that a potential decline in the number of COVID-19 deaths would be observed by September 2020 [<xref rid="pone.0254826.ref104" ref-type="bibr">104</xref>]. Therefore, the forecasting trends need to be interpreted cautiously to inform policies. The IHME model also shows a decline in COVID-19 deaths in Mexico from mid-August-September, which have stabilized since then for the last six forecast periods (<xref rid="pone.0254826.s006" ref-type="supplementary-material">S5 Fig</xref>). The sub-epidemic model also indicates a stabilization of the deaths for the last seven forecast periods (<xref rid="pone.0254826.s007" ref-type="supplementary-material">S6 Fig</xref>) consistent with the results obtained from the IHME model.</p>
              <p>Similarly, for Mexico City, the sequential forecasts obtained from the GLM and Richards model fitted to the daily death data estimates indicate a decline in the overall deaths (<xref rid="pone.0254826.s004" ref-type="supplementary-material">S3</xref> and <xref rid="pone.0254826.s005" ref-type="supplementary-material">S4</xref> Figs). The IHME and sub-epidemic models on the other hand indicate a stabilization in the trajectory of mortality trends for the last three forecast periods (<xref rid="pone.0254826.s008" ref-type="supplementary-material">S7</xref> and <xref rid="pone.0254826.s009" ref-type="supplementary-material">S8</xref> Figs), suggesting that the actual death counts might not be decreasing in Mexico City as seen with Mexico. Based on the mortality data, the observed decline or stability in death predictions could likely reflect the false slowing down of the pandemic in Mexico City [<xref rid="pone.0254826.ref103" ref-type="bibr">103</xref>]. Moreover, insufficient testing can also result in an inaccurate trajectory of the COVID-19 mortality curve [<xref rid="pone.0254826.ref105" ref-type="bibr">105</xref>].</p>
              <p>The cumulative comparison of deaths in Mexico and Mexico City indicates that in general, the Richards model has under-performed in predicting the actual death counts with much wider uncertainty around the mean death estimates. The Richards model has also failed to capture the early sub-exponential growth dynamics of the mortality curve. The cumulative death counts obtained from the flexible sub-epidemic model closely approximate the total mean death counts obtained from the three IHME modeling scenarios. Whereas the GLM slightly under predicts the cumulative death counts (Figs <xref rid="pone.0254826.g006" ref-type="fig">6</xref> and <xref rid="pone.0254826.g007" ref-type="fig">7</xref>). Another competing model, the COVID-19 predictions model projects 87,151 deaths (95% PI: [84,414, 91,883]) for Mexico as of October 27, 2020 (last forecasting phase), an estimate that closely approximates the estimate obtained from the GLM model (between 77,258–93,454 deaths) [<xref rid="pone.0254826.ref106" ref-type="bibr">106</xref>].</p>
              <p>The three phenomenological models (GLM, Richards, sub-epidemic wave model) used in this study generally provide good fits to the mortality curves based on the residuals. However, the Richards model is unable to capture the early sub-exponential dynamics of the mortality curve. These phenomenological models are particularly valuable for providing rapid predictions of the epidemics in complex scenarios that can be used for real-time preparedness since these models do not require specific disease transmission processes to account for the interventions. Since these models do not explicitly account for behavioral changes, the results should be interpreted with caution. Importantly, since the mortality curves employed in this study are reported according to the date of reporting, they are likely influenced by variation in the testing rates and related factors including the case fatality rates. Further, delays in reporting of deaths due to the magnitude of the epidemic could also influence our predictions. Moreover, using the reporting date is not ideal due to the time difference between the date of death and the reporting date of death, which at a given moment can provide a false impression of the ongoing circumstances.</p>
              <p>Our study is not exempt from limitations. First, the IHME (current projections, mandated mask, and worst-case scenario) model utilized has been revised multiple times over the course of the pandemic and differs substantially in methodology, assumptions, range of predictions, and quantities estimated. Second, the IHME has been irregular in publishing the downloadable estimates online for some periods. Third, we model the death estimates by date of reporting rather than by the date of death. Lastly, the unpredictable social component of the epidemic on the ground is also a limiting factor for the study as we do not know the ground truth mortality pattern when the forecasts are generated.</p>
              <p>In conclusion, the reproduction number has been fluctuating around ~1.0 since the end of July-end of September 2020, indicating sustained virus transmission in the region. Simultaneously, the country has seen much lower mobility reduction and mixed compliance with stay-at-home orders contributing towards the virus transmission in the country. Moreover, the spatial analysis indicates that states like Mexico, Michoacán, Morelos, Nuevo Leon, Baja California require stronger public health strategies to contain the rising patterns in epidemic growth rates. The GLM and sub-epidemic model applied to mortality data in Mexico provide reasonable estimates for short-term projections in near real-time. While the GLM and Richards models predict that the COVID-19 outbreak in Mexico and Mexico City may be on a sustained decline, the sub-epidemic and IHME model predict a stabilization of daily deaths. However, the forecasts need to be interpreted with caution given the dynamic implementation and lifting of the social distancing measures.</p>
            </sec>
            <sec id="sec034" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0254826.s001" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0254826.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s002" position="float" content-type="local-data">
                <label>S1 Fig</label>
                <caption>
                  <title>COVID-19 deaths forecasts using daily deaths, GLM model, Mexico: 30-days ahead forecasts based on the Generalized Logistic Growth model (GLM) calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s002.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s003" position="float" content-type="local-data">
                <label>S2 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, Richards model, Mexico: 30-days ahead forecasts based on the Richards model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s003.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s004" position="float" content-type="local-data">
                <label>S3 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, GLM model, Mexico City: 30-days ahead forecasts based on the GLM model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s004.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s005" position="float" content-type="local-data">
                <label>S4 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, Richards model, Mexico City: 30-days ahead forecasts based on the Richards model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s005.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s006" position="float" content-type="local-data">
                <label>S5 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, IHME model, Mexico: 30-days ahead forecasts based on the IHME model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s006.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s007" position="float" content-type="local-data">
                <label>S6 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, sub-epidemic wave model, Mexico: 30-days ahead forecasts based on the sub-epidemic wave model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s007.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s008" position="float" content-type="local-data">
                <label>S7 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, IHME model, Mexico City: 30-days ahead forecasts based on the IHME model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s008.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s009" position="float" content-type="local-data">
                <label>S8 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using daily deaths, sub-epidemic wave model, Mexico City: 30-days ahead forecasts based on the sub-epidemic wave model calibrated using an increasing amount of daily death data (blue circles): 107, 114, 120, 128, 136, 151, 156, 164, 172, 179, 185, 193, 193 epidemic days.</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s009.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s010" position="float" content-type="local-data">
                <label>S9 Fig</label>
                <caption>
                  <title>COVID-19 deaths forecasts using cumulative deaths, GLM model, Mexico: 30-days ahead forecasts based on the Generalized Logistic Growth model (GLM) calibrated using an increasing amount of cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s010.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s011" position="float" content-type="local-data">
                <label>S10 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, IHME model, Mexico: 30-day ahead forecasts based on the IHME model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s011.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s012" position="float" content-type="local-data">
                <label>S11 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, Richards model, Mexico: 30-day ahead forecasts based on the Richards model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s012.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s013" position="float" content-type="local-data">
                <label>S12 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, sub-epidemic wave model, Mexico: 30-day ahead forecasts based on the Sub-epidemic wave model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s013.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s014" position="float" content-type="local-data">
                <label>S13 Fig</label>
                <caption>
                  <title>COVID-19 deaths forecasts using cumulative deaths, GLM model, Mexico City: 30-day ahead forecasts based on the Generalized Logistic Growth model (GLM) calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s014.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s015" position="float" content-type="local-data">
                <label>S14 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, IHME model, Mexico City: 30-day ahead forecasts based on the IHME model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s015.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s016" position="float" content-type="local-data">
                <label>S15 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, Richards model, Mexico City: 30-day ahead forecasts based on the Richards model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s016.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s017" position="float" content-type="local-data">
                <label>S16 Fig</label>
                <caption>
                  <title>COVID-19 death forecasts using cumulative deaths, sub-epidemic wave model, Mexico City: 30-day ahead forecasts based on the Sub-epidemic wave model calibrated using cumulative death data (blue circles).</title>
                  <p>The vertical dashed line indicates the end of the calibration period and start of the forecasting period. The mean (solid red line) and 95% PIs (dashed red lines) of the model fit and forecast are shown.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s017.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s018" position="float" content-type="local-data">
                <label>S17 Fig</label>
                <caption>
                  <title>Pre-processing COVID-19 data into incidence rate functions.</title>
                  <p>From left to right: original lab-confirmed COVID-19 cases, curve of daily new cases, smoothed and scaled rate curves, average of rate curves before scaling and smothing.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s018.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s019" position="float" content-type="local-data">
                <label>S18 Fig</label>
                <caption>
                  <title>Clustering of states according to the shapes of their rate curves.</title>
                  <p>The largest cluster–cluster 1 –is shown in green while the smallest cluster–cluster 3 –is shown in the black. One can see that states with similar shapes of rates curves are geographically close to each other.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s019.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s020" position="float" content-type="local-data">
                <label>S19 Fig</label>
                <caption>
                  <title>Average shapes of the COVID-19 incidence rate curves, along with a one standard-deviation band around the average, in each of the clusters.</title>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s020.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s021" position="float" content-type="local-data">
                <label>S20 Fig</label>
                <caption>
                  <title>Cluster averages and the overall average.</title>
                  <p>These averages represent the four dominant patterns of incidence rates observed across all states.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s021.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s022" position="float" content-type="local-data">
                <label>S21 Fig</label>
                <caption>
                  <title>Total number of COVID-19 cases as of December 5, 2020.</title>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s022.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0254826.s023" position="float" content-type="local-data">
                <label>S22 Fig</label>
                <caption>
                  <title>COVID-19 epi-curve overlaid by the curve of stay-at-home orders tweets.</title>
                  <p>Blue line indicates the number of cases by dates of onset and the orange line indicates the number of tweets referring to the stay-at-home orders.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0254826.s023.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0254826.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>NP</given-names></name>, <name><surname>Mueller</surname><given-names>J</given-names></name>. <article-title>Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic</article-title>. <source>Bull Hist Med</source>. <year>2002</year>;<volume>76</volume>(<issue>1</issue>):<fpage>105</fpage>–<lpage>15</lpage>. Epub 2002/03/05. <comment>doi: </comment><pub-id pub-id-type="doi">10.1353/bhm.2002.0022</pub-id> .<?supplied-pmid 11875246?><pub-id pub-id-type="pmid">11875246</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Fernández-Rojas</surname><given-names>MA</given-names></name>, <name><surname>Luna-Ruiz Esparza</surname><given-names>MA</given-names></name>, <name><surname>Campos-Romero</surname><given-names>A</given-names></name>, <name><surname>Calva-Espinosa</surname><given-names>DY</given-names></name>, <name><surname>Moreno-Camacho</surname><given-names>JL</given-names></name>, <name><surname>Langle-Martínez</surname><given-names>AP</given-names></name>, <etal>et al</etal>. <article-title>Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people</article-title>. <source>Int J Infect Dis</source><year>2021</year>;<volume>104</volume>:<fpage>572</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijid.2020.12.086</pub-id>
<?supplied-pmid 33434668?><pub-id pub-id-type="pmid">33434668</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref003">
                <label>3</label>
                <mixed-citation publication-type="book"><name><surname>Cascella</surname><given-names>M</given-names></name>, <name><surname>Rajnik</surname><given-names>M</given-names></name>, <name><surname>Cuomo</surname><given-names>A</given-names></name>, <name><surname>Dulebohn</surname><given-names>SC</given-names></name>, <name><surname>Di Napoli</surname><given-names>R</given-names></name>. <chapter-title>Features, Evaluation, and Treatment of Coronavirus (COVID-19)</chapter-title>. <source>StatPearls</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>, 2021, <publisher-name>StatPearls Publishing LLC</publisher-name>.; <year>2021</year>. .<?supplied-pmid 32150360?></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Feng</surname><given-names>L</given-names></name>, <name><surname>Rodewald</surname><given-names>L</given-names></name>, <name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Active case finding with case management: the key to tackling the COVID-19 pandemic</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>396</volume>(<issue>10243</issue>):<fpage>63</fpage>–<lpage>70</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31278-2</pub-id>
<?supplied-pmid 32505220?><pub-id pub-id-type="pmid">32505220</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref005">
                <label>5</label>
                <mixed-citation publication-type="other">WHO. COVID-19 Weekly Epidemiological Update World Health Organization. 2020 [cited 2020 December 30]. Available from: <ext-link xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports" ext-link-type="uri">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref006">
                <label>6</label>
                <mixed-citation publication-type="other">WHO. Situation Reports Coronavirus World Health Organization. 2020 [cited 2020 December 30]. Available from: <ext-link xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports" ext-link-type="uri">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref007">
                <label>7</label>
                <mixed-citation publication-type="other">WHO. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization. 2003 [cited 2020 September 20]. Available from: <ext-link xlink:href="https://www.who.int/csr/sars/country/table2004_04_21/en/" ext-link-type="uri">https://www.who.int/csr/sars/country/table2004_04_21/en/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref008">
                <label>8</label>
                <mixed-citation publication-type="book"><collab>WHO</collab>. <source>MERS situation update November 2019</source>. <publisher-name>World Health Organization</publisher-name>. <year>2019</year> [cited 2020 September 7]. Available from: <ext-link xlink:href="https://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1&amp;ua=1" ext-link-type="uri">https://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1&amp;ua=1</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>The</surname><given-names>L</given-names></name>. <article-title>COVID-19 vaccines: no time for complacency</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>396</volume>(<issue>10263</issue>):<fpage>1607</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32472-7</pub-id><?supplied-pmid 33220729?><pub-id pub-id-type="pmid">33220729</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Ledford</surname><given-names>H</given-names></name>. <article-title>US authorization of first COVID vaccine marks new phase in safety monitoring</article-title>. <source>Nature</source>. <year>2020</year>;(<issue>588</issue>):<fpage>377</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-020-03542-4</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Burki</surname><given-names>T</given-names></name>. <article-title>Understanding variants of SARS-CoV-2</article-title>. <source>The Lancet</source>. <year>2021</year>;<volume>397</volume>(<issue>10273</issue>):<fpage>462</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00298-1</pub-id><?supplied-pmid 33549181?><pub-id pub-id-type="pmid">33549181</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Reiner</surname><given-names>RC</given-names></name>, <name><surname>Barber</surname><given-names>RM</given-names></name>, <name><surname>Collins</surname><given-names>JK</given-names></name>, <name><surname>Zheng</surname><given-names>P</given-names></name>, <name><surname>Adolph</surname><given-names>C</given-names></name>, <name><surname>Albright</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Modeling COVID-19 scenarios for the United States</article-title>. <source>Nat Med</source>. <year>2021</year>;<volume>27</volume>(<issue>1</issue>):<fpage>94</fpage>–<lpage>105</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41591-020-1132-9</pub-id>
<?supplied-pmid 33097835?><pub-id pub-id-type="pmid">33097835</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Azanza Ricardo</surname><given-names>CL</given-names></name>, <name><surname>Hernandez Vargas</surname><given-names>EA</given-names></name>. <article-title>The Risk of Lifting COVID-19 Confinement in Mexico</article-title>. <source>medRxiv</source> 2020.05.28.20115063 [preprint] <year>2020</year> [cited 2021 February 3]. Available from: <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/2020.05.28.20115063</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Acuña-Zegarra</surname><given-names>MA</given-names></name>, <name><surname>Santana-Cibrian</surname><given-names>M</given-names></name>, <name><surname>Velasco-Hernandez</surname><given-names>JX</given-names></name>. <article-title>Modeling behavioral change and COVID-19 containment in Mexico: A trade-off between lockdown and compliance</article-title>. <source>Math Biosci</source>. <year>2020</year>;<volume>325</volume>:<fpage>108370</fpage>–. Epub 2020/05/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mbs.2020.108370</pub-id> .<?supplied-pmid 32387384?><pub-id pub-id-type="pmid">32387384</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Shuchman</surname><given-names>M</given-names></name>. <article-title>Low- and middle-income countries face up to COVID-19</article-title>. <source>Nat Med</source>. <year>2020</year>;(<issue>26</issue>):<fpage>986</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/d41591-020-00020-2</pub-id>
<?supplied-pmid 32439872?><pub-id pub-id-type="pmid">32439872</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Barnett-Howell</surname><given-names>Z</given-names></name>, <name><surname>Mobarak</surname><given-names>AM</given-names></name>. <source>Should Low-Income Countries Impose the Same Social Distancing Guidelines as Europe and North America to Halt the Spread of COVID-19?</source><year>2020</year> [cited 2020 September 20]. Available from: <ext-link xlink:href="https://som.yale.edu/should-low-income-countries-impose-the-same-social-distancing-guidelines-as-europe-and-north-america-to-halt-the-spread-of-covid-19" ext-link-type="uri">https://som.yale.edu/should-low-income-countries-impose-the-same-social-distancing-guidelines-as-europe-and-north-america-to-halt-the-spread-of-covid-19</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Regmi</surname><given-names>K</given-names></name>, <name><surname>Lwin</surname><given-names>CM</given-names></name>. <article-title>Impact of social distancing measures for preventing coronavirus disease 2019 [COVID-19]: A systematic review and meta-analysis protocol</article-title>. <source>medRxiv</source>. 2020.06.13.20130294 [preprint]. <year>2020</year> [cited 2020 December 28]. Available from: <ext-link xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.13.20130294v1" ext-link-type="uri">https://www.medrxiv.org/content/10.1101/2020.06.13.20130294v1</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref018">
                <label>18</label>
                <mixed-citation publication-type="other">MOH. Ministry of Health Mexico, Open Data General Directorate of Epidemiology 2020 [cited 2020 December 28]. Available from: <ext-link xlink:href="https://www.gob.mx/salud/documentos/datos-abiertos-152127" ext-link-type="uri">https://www.gob.mx/salud/documentos/datos-abiertos-152127</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref019">
                <label>19</label>
                <mixed-citation publication-type="other">Statistica. Number of people living in poverty in Mexico between 2008 and 2018 (in millions) 2019 [cited 2020 September 18]. Available from: <ext-link xlink:href="https://www.statista.com/statistics/1039479/mexico-people-living-poverty/" ext-link-type="uri">https://www.statista.com/statistics/1039479/mexico-people-living-poverty/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref020">
                <label>20</label>
                <mixed-citation publication-type="other">Coneval. Poverty measurement, poverty measurement in Mexico 2020 [cited 2020 December 16]. Available from: <ext-link xlink:href="https://www.coneval.org.mx/Medicion/Paginas/PobrezaInicio.aspx" ext-link-type="uri">https://www.coneval.org.mx/Medicion/Paginas/PobrezaInicio.aspx</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref021">
                <label>21</label>
                <mixed-citation publication-type="other">Organization IL. Informal employment in Mexico: Current situation, policies and challenges: FORLAC; 2014 [cited 2020 August 13]. Available from: <ext-link xlink:href="https://www.ilo.org/wcmsp5/groups/public/—americas/—rolima/documents/publication/wcms_245889.pdf" ext-link-type="uri">https://www.ilo.org/wcmsp5/groups/public/—americas/—rolima/documents/publication/wcms_245889.pdf</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Dahal</surname><given-names>S</given-names></name>, <name><surname>Banda</surname><given-names>JM</given-names></name>, <name><surname>Bento</surname><given-names>AI</given-names></name>, <name><surname>Mizumoto</surname><given-names>K</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico</article-title>. <source>BMC Infect Dis</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>432</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12879-021-06122-7</pub-id><?supplied-pmid 33962563?><pub-id pub-id-type="pmid">33962563</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Agren</surname><given-names>D</given-names></name>. <article-title>Understanding Mexican health worker COVID-19 deaths</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>396</volume>(<issue>10254</issue>):<fpage>807</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31955-3</pub-id><?supplied-pmid 32950079?><pub-id pub-id-type="pmid">32950079</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Carrillo-Vega</surname><given-names>MF</given-names></name>, <name><surname>Salinas-Escudero</surname><given-names>G</given-names></name>, <name><surname>García-Peña</surname><given-names>C</given-names></name>, <name><surname>Gutiérrez-Robledo</surname><given-names>LM</given-names></name>, <name><surname>Parra-Rodríguez</surname><given-names>L</given-names></name>. <article-title>Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico</article-title>. <source>PLoS ONE</source>. <year>2020</year>;<volume>15</volume>(<issue>9</issue>):<fpage>e0238905</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0238905</pub-id><?supplied-pmid 32915872?><pub-id pub-id-type="pmid">32915872</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Montes</surname><given-names>J</given-names></name>. <article-title>Covid-19 Takes Outsize Toll on Mexican Health Workers</article-title>. <source>The Wall St J</source>. <year>2021</year><month>January</month><day>9</day>. Available from: <ext-link xlink:href="https://www.wsj.com/articles/covid-19-takes-outsize-toll-on-mexican-health-workers-11610214842" ext-link-type="uri">https://www.wsj.com/articles/covid-19-takes-outsize-toll-on-mexican-health-workers-11610214842</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref026">
                <label>26</label>
                <mixed-citation publication-type="other">Total COVID-19 tests per 1,000 people: Our World in Data; 2020 [cited 2020 September 24]. Available from: <ext-link xlink:href="https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand?time=2020-02-21..latest&amp;country=BRA~CHL~SLV~MEX~PER" ext-link-type="uri">https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand?time=2020-02-21..latest&amp;country=BRA~CHL~SLV~MEX~PER</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref027">
                <label>27</label>
                <mixed-citation publication-type="book"><name><surname>Moreno</surname><given-names>T</given-names></name>. <source>Mexico’s COVID-19 contingency plan: three key phases to fight the coronavirus outbreak</source>: <publisher-name>El Universal</publisher-name>; <year>2020</year><month>March</month><day>14</day> [cited 2020 July 27]. Available from: <ext-link xlink:href="https://www.eluniversal.com.mx/english/mexicos-covid-19-contingency-plan-three-key-phases-fight-coronavirus-outbreak" ext-link-type="uri">https://www.eluniversal.com.mx/english/mexicos-covid-19-contingency-plan-three-key-phases-fight-coronavirus-outbreak</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref028">
                <label>28</label>
                <mixed-citation publication-type="other">Drafting. There are 3 confirmed cases of coronavirus in Mexico: Elfinanciero; 2020 February 28 [cited 2020 June 4]. Available from: <ext-link xlink:href="https://elfinanciero.com.mx/salud/van-3-casos-confirmados-de-coronavirus-en-mexico" ext-link-type="uri">https://elfinanciero.com.mx/salud/van-3-casos-confirmados-de-coronavirus-en-mexico</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref029">
                <label>29</label>
                <mixed-citation publication-type="other">Informer T. Massive Activities Due to Coronavirus Suspended: Informador.Mx; 2020 March 13 [cited 2020 July 17]. Available from: <ext-link xlink:href="https://www.informador.mx/mexico/Suspenden-actividades-masivas-por-coronavirus-20200313-0020.html" ext-link-type="uri">https://www.informador.mx/mexico/Suspenden-actividades-masivas-por-coronavirus-20200313-0020.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>L</given-names></name>. <article-title>Covid-19: How denialism led Mexico’s disastrous pandemic control effort</article-title>. <source>BMJ</source>. <year>2020</year>;<volume>371</volume>:<fpage>m4952</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.m4952</pub-id><?supplied-pmid 33380418?><pub-id pub-id-type="pmid">33380418</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref031">
                <label>31</label>
                <mixed-citation publication-type="other">Agren D. Mexico holds off canceling mass gatherings amid coronavirus threat: USA Today; 2020 March 14 [cited 2020 August 16]. Available from: <ext-link xlink:href="https://www.usatoday.com/story/news/world/2020/03/14/coronavirus-mexico-holds-off-canceling-mass-gatherings-amid-pandemic/5049632002/" ext-link-type="uri">https://www.usatoday.com/story/news/world/2020/03/14/coronavirus-mexico-holds-off-canceling-mass-gatherings-amid-pandemic/5049632002/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Caicedo-Ochoa</surname><given-names>Y</given-names></name>, <name><surname>Rebellón-Sánchez</surname><given-names>DE</given-names></name>, <name><surname>Peñaloza-Rallón</surname><given-names>M</given-names></name>, <name><surname>Cortés-Motta</surname><given-names>HF</given-names></name>, <name><surname>Méndez-Fandiño</surname><given-names>YR</given-names></name>. <article-title>Effective Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin American Countries</article-title>. <source>Int J of Infect Dis</source>. <year>2020</year>;<volume>95</volume>:<fpage>316</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijid.2020.04.069</pub-id>
<?supplied-pmid 32360941?><pub-id pub-id-type="pmid">32360941</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Ibarra-Nava</surname><given-names>I</given-names></name>, <name><surname>Cardenas-de la Garza</surname><given-names>JA</given-names></name>, <name><surname>Ruiz-Lozano</surname><given-names>RE</given-names></name>, <name><surname>Salazar-Montalvo</surname><given-names>RG</given-names></name>. <article-title>Mexico and the COVID-19 Response</article-title>. <source>Disaster Med Public Health Prep</source>. <year>2020</year>;<volume>14</volume>(<issue>4</issue>):<fpage>e17</fpage>–<lpage>e8</lpage>. Epub 2020/07/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/dmp.2020.260</pub-id>
<?supplied-pmid 32713412?><pub-id pub-id-type="pmid">32713412</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Suárez</surname><given-names>V</given-names></name>, <name><surname>Suarez Quezada</surname><given-names>M</given-names></name>, <name><surname>Oros Ruiz</surname><given-names>S</given-names></name>, <name><surname>Ronquillo De Jesús</surname><given-names>E</given-names></name>. <article-title>Epidemiology of COVID-19 in Mexico: From the 27th of February to the 30th of April 2020</article-title>. <source>Rev Clin Esp (Barc)</source>. <year>2020</year>;<volume>220</volume>(<issue>8</issue>):<fpage>463</fpage>–<lpage>71</lpage>. Epub 2020/07/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rceng.2020.05.008</pub-id> PMC7343663. <?supplied-pmid 32560915?><pub-id pub-id-type="pmid">32560915</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref035">
                <label>35</label>
                <mixed-citation publication-type="other">GardaWorld. Mexico: Government enters phase 2 of COVID-19 contingency plan on March 24 /update 3: GradaWorld; 2020 March 18 [cited 2020 August 16]. Available from: <ext-link xlink:href="https://www.garda.com/crisis24/news-alerts/327221/mexico-government-enters-phase-2-of-covid-19-contingency-plan-on-march-24-update-3" ext-link-type="uri">https://www.garda.com/crisis24/news-alerts/327221/mexico-government-enters-phase-2-of-covid-19-contingency-plan-on-march-24-update-3</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref036">
                <label>36</label>
                <mixed-citation publication-type="book"><collab>Interior Mot</collab>. <chapter-title>Agreement establishing the preventive measures that must be implemented to mitigate and control the health risks posed by the disease caused by the SARS-CoV2 virus (COVID-19)</chapter-title>. <publisher-name>Ministry of the Interior, Official Gazette of the Federation</publisher-name>.<year>2020</year><month>March</month><day>24</day> [cited 2020 July 17]. Available from: <ext-link xlink:href="https://www.dof.gob.mx/nota_detalle.php?codigo=5590339&amp;fecha=24/03/2020" ext-link-type="uri">https://www.dof.gob.mx/nota_detalle.php?codigo=5590339&amp;fecha=24/03/2020</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref037">
                <label>37</label>
                <mixed-citation publication-type="other">GardaWorld. Mexico: Authorities declare health emergency as COVID-19 cases exceed 1000 March 30 /update 4: GardaWorld; 2020 March 31 [cited 2020 August 26]. Available from: <ext-link xlink:href="https://www.garda.com/crisis24/news-alerts/327711/mexico-authorities-declare-health-emergency-as-covid-19-cases-exceed-1000-march-30-update-4" ext-link-type="uri">https://www.garda.com/crisis24/news-alerts/327711/mexico-authorities-declare-health-emergency-as-covid-19-cases-exceed-1000-march-30-update-4</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref038">
                <label>38</label>
                <mixed-citation publication-type="other">Fredrick J. ’If Coronavirus Doesn’t Kill Me, Hunger Will’: Mexico’s Poor Bear Brunt Of Pandemic: Npr; 2020 July 30 [cited 2020 July 31]. Available from: <ext-link xlink:href="https://www.npr.org/2020/07/30/895698797/if-coronavirus-doesn-t-kill-me-hunger-will-mexico-s-poor-bear-brunt-of-pandemic" ext-link-type="uri">https://www.npr.org/2020/07/30/895698797/if-coronavirus-doesn-t-kill-me-hunger-will-mexico-s-poor-bear-brunt-of-pandemic</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref039">
                <label>39</label>
                <mixed-citation publication-type="other">Blust K. Sonoran authorities will enforce strict stay-at-home order through April 30: News Azpm; 2020 April 13 [cited 2020 July 6]. Available from: <ext-link xlink:href="https://news.azpm.org/p/coronavirus/2020/4/13/169980-sonoran-authorities-will-enforce-strict-stay-at-home-order-through-april-30/" ext-link-type="uri">https://news.azpm.org/p/coronavirus/2020/4/13/169980-sonoran-authorities-will-enforce-strict-stay-at-home-order-through-april-30/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref040">
                <label>40</label>
                <mixed-citation publication-type="other">Wall SAA. Be okay with the "stay home": Psico Grupo; 2020 May 21 [cited 2020 July 7]. Available from: <ext-link xlink:href="https://psicogrupo.com/covid-19/estar-bien-con-el-quedate-en-casa/" ext-link-type="uri">https://psicogrupo.com/covid-19/estar-bien-con-el-quedate-en-casa/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref041">
                <label>41</label>
                <mixed-citation publication-type="other">AP. Mexico to restrict mobility to areas less affected by virus: AP News; 2020 April 16 [cited 2020 August 8]. Available from: <ext-link xlink:href="https://apnews.com/9e5bb61c8bb22aba3fe0557aa82f592e" ext-link-type="uri">https://apnews.com/9e5bb61c8bb22aba3fe0557aa82f592e</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref042">
                <label>42</label>
                <mixed-citation publication-type="book"><collab>Universal E</collab>. <source>Mexico enters Phase 3 of its contingency plan to fight COVID-19</source>: <publisher-name>El Universal</publisher-name>; <year>2020</year><month>April</month><day>4</day> [cited 2020 August 9]. Available from: <ext-link xlink:href="https://www.eluniversal.com.mx/english/mexico-enters-phase-3-its-contingency-plan-fight-covid-19" ext-link-type="uri">https://www.eluniversal.com.mx/english/mexico-enters-phase-3-its-contingency-plan-fight-covid-19</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Capistran</surname><given-names>MA</given-names></name>, <name><surname>Capella</surname><given-names>A</given-names></name>, <name><surname>Christen</surname><given-names>JA</given-names></name>. <article-title>Forecasting hospital demand in metropolitan areas during the current COVID-19 pandemic and estimates of lockdown-induced 2nd waves</article-title>. <source>PLoS ONE</source>. <year>2021</year>;<volume>16</volume>(<issue>1</issue>):<fpage>e0245669</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0245669</pub-id><?supplied-pmid 33481925?><pub-id pub-id-type="pmid">33481925</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref044">
                <label>44</label>
                <mixed-citation publication-type="other">Oré D. Exclusive: ’We’re winning’—Mexico’s coronavirus czar sees victory in sight: Reuters; 2020 May 5 [cited 2020 July 22]. Available from: <ext-link xlink:href="https://www.reuters.com/article/us-health-coronavirus-mexico-minister-ex/exclusive-were-winning-mexicos-coronavirus-czar-sees-victory-in-sight-idUSKBN22H2RV" ext-link-type="uri">https://www.reuters.com/article/us-health-coronavirus-mexico-minister-ex/exclusive-were-winning-mexicos-coronavirus-czar-sees-victory-in-sight-idUSKBN22H2RV</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref045">
                <label>45</label>
                <mixed-citation publication-type="other">Ahmed A, Kurmanaev A, Politi D, Londoño E. Virus Gains Steam Across Latin America: NewYork Times; 2020 June 23 [cited 2020 July 27]. Available from: <ext-link xlink:href="https://www.nytimes.com/2020/06/23/world/americas/coronavirus-brazil-mexico-peru-chile-uruguay.html?auth=login-google" ext-link-type="uri">https://www.nytimes.com/2020/06/23/world/americas/coronavirus-brazil-mexico-peru-chile-uruguay.html?auth=login-google</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref046">
                <label>46</label>
                <mixed-citation publication-type="other">Flores J. Did the mathematical model fail? Nexos: Nexos; 2020 [updated July 9; cited 2020 July 27]. Available from: <ext-link xlink:href="https://datos.nexos.com.mx/?p=1485" ext-link-type="uri">https://datos.nexos.com.mx/?p=1485</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref047">
                <label>47</label>
                <mixed-citation publication-type="other">Press A. Mexico President Kicks off ’New Normal’ Phase Amid Pandemic: US News; 2020 June 1 [cited 2020 July 18]. Available from: <ext-link xlink:href="https://www.usnews.com/news/world/articles/2020-06-01/mexico-president-kicks-off-new-normal-phase-amid-pandemic" ext-link-type="uri">https://www.usnews.com/news/world/articles/2020-06-01/mexico-president-kicks-off-new-normal-phase-amid-pandemic</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><collab>Review TNL</collab>. <article-title>Mexico’s COVID-19 Traffic Light Monitoring System</article-title>: <source>News for April 12</source>–<volume>25</volume>, <fpage>2021</fpage>. <source>The National Law Review</source>. <year>2021</year>;<volume>XI</volume>(<issue>111</issue>).</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Hincapie-Palacio</surname><given-names>D</given-names></name>, <name><surname>Ospina</surname><given-names>J</given-names></name>, <name><surname>Pell</surname><given-names>B</given-names></name>, <name><surname>Tariq</surname><given-names>A</given-names></name>, <name><surname>Dahal</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Using Phenomenological Models to Characterize Transmissibility and Forecast Patterns and Final Burden of Zika Epidemics</article-title>. <source>PLoS Curr</source>. <year>2016</year>;<fpage>8</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583</pub-id> .<?supplied-pmid 27366586?><pub-id pub-id-type="pmid">27366586</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Pell</surname><given-names>B</given-names></name>, <name><surname>Kuang</surname><given-names>Y</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Using phenomenological models for forecasting the 2015 Ebola challenge</article-title>. <source>Epidemics</source>. <year>2018</year>;<volume>22</volume>:<fpage>62</fpage>–<lpage>70</lpage>. Epub 2016/12/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.epidem.2016.11.002</pub-id> .<?supplied-pmid 27913131?><pub-id pub-id-type="pmid">27913131</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref051">
                <label>51</label>
                <mixed-citation publication-type="other">IHME. COVID-19 Projections 2020 [updated December 10; cited 2020 December 10]. Available from: <ext-link xlink:href="https://covid19.healthdata.org/mexico" ext-link-type="uri">https://covid19.healthdata.org/mexico</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref052">
                <label>52</label>
                <mixed-citation publication-type="other">Apple. Mobility Trends Reports Apple 2020 [cited 2020 December 6]. Available from: <ext-link xlink:href="https://covid19.apple.com/mobility" ext-link-type="uri">https://covid19.apple.com/mobility</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref053">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>Shu</surname><given-names>Y</given-names></name>, <name><surname>McCauley</surname><given-names>J</given-names></name>. <article-title>GISAID: Global initiative on sharing all influenza data—from vision to reality</article-title>. <source>Euro Surveill</source><year>2017</year>;<volume>22</volume>(<issue>13</issue>):<fpage>30494</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.13.30494</pub-id> .<?supplied-pmid 28382917?><pub-id pub-id-type="pmid">28382917</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Banda</surname><given-names>JM</given-names></name>, <name><surname>Tekumalla</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Ding</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>A large-scale COVID-19 Twitter chatter dataset for open scientific research—an international collaboration</article-title>. <source>arXiv:2004.03688v1</source> [Preprint]. ArXiv <year>2020</year>. [cited 2020 October 28]. Available from: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280901/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280901/</ext-link>
<?supplied-pmid 32550247?><pub-id pub-id-type="pmid">32550247</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Tariq</surname><given-names>A</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>. <article-title>A novel sub-epidemic modeling framework for short-term forecasting epidemic waves</article-title>. <source>BMC Med</source>. <year>2019</year>;<volume>17</volume>(<issue>1</issue>):<fpage>164</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12916-019-1406-6</pub-id><?supplied-pmid 31438953?><pub-id pub-id-type="pmid">31438953</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Shanafelt</surname><given-names>DW</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>, <name><surname>Lima</surname><given-names>M</given-names></name>, <name><surname>Perrings</surname><given-names>C</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Forecasting the 2001 Foot-and-Mouth Disease Epidemic in the UK</article-title>. <source>Ecohealth</source>. <year>2018</year>;<volume>15</volume>(<issue>2</issue>):<fpage>338</fpage>–<lpage>47</lpage>. Epub 2017/12/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10393-017-1293-2</pub-id> .<?supplied-pmid 29238900?><pub-id pub-id-type="pmid">29238900</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Roosa</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>Y</given-names></name>, <name><surname>Luo</surname><given-names>R</given-names></name>, <name><surname>Kirpich</surname><given-names>A</given-names></name>, <name><surname>Rothenberg</surname><given-names>R</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13–23, 2020</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>596</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/jcm9020596</pub-id> .<?supplied-pmid 32098289?><pub-id pub-id-type="pmid">32098289</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Roosa</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>Y</given-names></name>, <name><surname>Luo</surname><given-names>R</given-names></name>, <name><surname>Kirpich</surname><given-names>A</given-names></name>, <name><surname>Rothenberg</surname><given-names>R</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;<volume>5</volume>:<fpage>256</fpage>–<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.idm.2020.02.002</pub-id>
<?supplied-pmid 32110742?><pub-id pub-id-type="pmid">32110742</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>FJ</given-names></name>. <article-title>A Flexible Growth Function for Empirical Use</article-title>. <source>J Exp Bot</source>. <year>1959</year>;<volume>10</volume>(<issue>2</issue>):<fpage>290</fpage>–<lpage>301</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jxb/10.2.290</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref060">
                <label>60</label>
                <mixed-citation publication-type="book"><name><surname>Banks</surname><given-names>HT</given-names></name>, <name><surname>Hu</surname><given-names>S</given-names></name>, <name><surname>Thompson</surname><given-names>WC</given-names></name>. <source>Modeling and inverse problems in the presence of uncertainty</source>. <edition designator="1">1st ed</edition>. <publisher-name>Chapman and Hall/CRC Press</publisher-name>; <year>2019</year>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Fitting dynamic models to epidemic outbreaks with quantified uncertainty: A primer for parameter uncertainty, identifiability, and forecasts</article-title>. <source>Infect Dis Model</source>. <year>2017</year>;<volume>2</volume>(<issue>3</issue>):<fpage>379</fpage>–<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.idm.2017.08.001</pub-id>
<?supplied-pmid 29250607?><pub-id pub-id-type="pmid">29250607</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref062">
                <label>62</label>
                <mixed-citation publication-type="other">Mathworks. lhs design [cited 2020 November 20]. Available from: <ext-link xlink:href="https://www.mathworks.com/help/stats/lhsdesign.html" ext-link-type="uri">https://www.mathworks.com/help/stats/lhsdesign.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Roosa</surname><given-names>K</given-names></name>, <name><surname>Luo</surname><given-names>R</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Comparative assessment of parameter estimation methods in the presence of overdispersion: a simulation study</article-title>. <source>Math Biosci Eng</source>. <year>2019</year>;<volume>16</volume>(<issue>5</issue>):<fpage>4299</fpage>–<lpage>313</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3934/mbe.2019214</pub-id>
<?supplied-pmid 31499663?><pub-id pub-id-type="pmid">31499663</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Roosa</surname><given-names>K</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Assessing parameter identifiability in compartmental dynamic models using a computational approach: application to infectious disease transmission models</article-title>. <source>Theor Biol Med Model</source>. <year>2019</year>;<volume>16</volume>(<issue>1</issue>):<fpage>1</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12976-018-0097-6</pub-id><?supplied-pmid 30642334?><pub-id pub-id-type="pmid">30642334</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref065">
                <label>65</label>
                <mixed-citation publication-type="book"><name><surname>Kuhn</surname><given-names>M</given-names></name>, <name><surname>Johnson</surname><given-names>K</given-names></name>. <source>Applied predictive modeling</source>. <edition designator="1">1st ed</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref066">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Gneiting</surname><given-names>T</given-names></name>, <name><surname>Raftery</surname><given-names>AE</given-names></name>. <article-title>Strictly Proper Scoring Rules, Prediction, and Estimation</article-title>. <source>J Am Stat Assoc</source>. <year>2007</year>;<volume>102</volume>(<issue>477</issue>):<fpage>359</fpage>–<lpage>78</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1198/016214506000001437</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref067">
                <label>67</label>
                <mixed-citation publication-type="other">Healy K. Apple’s COVID Mobility Data Github: Github; 2020 [cited 2020 December 1]. Available from: <ext-link xlink:href="https://github.com/kjhealy/apple_covid_post/blob/master/apple.Rmd" ext-link-type="uri">https://github.com/kjhealy/apple_covid_post/blob/master/apple.Rmd</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Abdirizak</surname><given-names>F</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Jung</surname><given-names>E</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study</article-title>. <source>BMC Med</source>. <year>2015</year>;<volume>13</volume>(<issue>1</issue>):<fpage>210</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12916-015-0450-0</pub-id><?supplied-pmid 26336062?><pub-id pub-id-type="pmid">26336062</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref069">
                <label>69</label>
                <mixed-citation publication-type="book"><name><surname>Anderson</surname><given-names>RM</given-names></name>, <name><surname>May</surname><given-names>RM</given-names></name>. <source>Infectious Diseases of Humans</source>. <edition designator="1">1st ed</edition>. <publisher-loc>Oxford</publisher-loc>, editor. <publisher-name>Oxford Univeristy Press</publisher-name><year>1991</year>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Heesterbeek</surname><given-names>H</given-names></name>, <name><surname>Wallinga</surname><given-names>J</given-names></name>. <article-title>The ideal reporting interval for an epidemic to objectively interpret the epidemiological time course</article-title>. <source>J R Soc Interface</source>. <year>2010</year>;<volume>7</volume>(<issue>43</issue>):<fpage>297</fpage>–<lpage>307</lpage>. Epub 2009/07/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1098/rsif.2009.0153</pub-id> .<?supplied-pmid 19570792?><pub-id pub-id-type="pmid">19570792</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Simonsen</surname><given-names>L</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>A generalized-growth model to characterize the early ascending phase of infectious disease outbreaks</article-title>. <source>Epidemics</source>. <year>2016</year>;<volume>15</volume>:<fpage>27</fpage>–<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.epidem.2016.01.002</pub-id>
<?supplied-pmid 27266847?><pub-id pub-id-type="pmid">27266847</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Ganyani</surname><given-names>T</given-names></name>, <name><surname>Kremer</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>D</given-names></name>, <name><surname>Torneri</surname><given-names>A</given-names></name>, <name><surname>Faes</surname><given-names>C</given-names></name>, <name><surname>Wallinga</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020</article-title>. <source>Euro Surveill</source>. <year>2020</year>;<volume>25</volume>(<issue>17</issue>):<fpage>2000257</fpage>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.17.2000257</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014</article-title>. <source>Euro Surveill</source>. <year>2014</year>;<volume>19</volume>(<issue>36</issue>). Epub 2014/09/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.2807/1560-7917.es2014.19.36.20894</pub-id> .<?supplied-pmid 25232919?><pub-id pub-id-type="pmid">25232919</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref074">
                <label>74</label>
                <mixed-citation publication-type="book"><name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <source>The Effective Reproduction Number as a Prelude to Statistical Estimation of Time-Dependent Epidemic Trends</source>. <publisher-name>Springer</publisher-name>, editor <year>2009</year>. <fpage>103</fpage>–<lpage>12</lpage> p.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref075">
                <label>75</label>
                <mixed-citation publication-type="journal"><name><surname>Paine</surname><given-names>S</given-names></name>, <name><surname>Mercer</surname><given-names>G</given-names></name>, <name><surname>Kelly</surname><given-names>P</given-names></name>, <name><surname>Bandaranayake</surname><given-names>D</given-names></name>, <name><surname>Baker</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations</article-title>. <source>Euro Surveill</source>. <year>2010</year>;<volume>15</volume>(<issue>24</issue>). Epub 2010/06/26. .<?supplied-pmid 20576236?><pub-id pub-id-type="pmid">20576236</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Fraser</surname><given-names>C</given-names></name>. <article-title>Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic</article-title>. <source>PLoS ONE</source>. <year>2007</year>;<volume>2</volume>(<issue>8</issue>):<fpage>e758</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0000758</pub-id><?supplied-pmid 17712406?><pub-id pub-id-type="pmid">17712406</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Chong</surname><given-names>KC</given-names></name>, <name><surname>Zee</surname><given-names>BCY</given-names></name>, <name><surname>Wang</surname><given-names>MH</given-names></name>. <article-title>Approximate Bayesian algorithm to estimate the basic reproduction number in an influenza pandemic using arrival times of imported cases</article-title>. <source>Travel Med Infect Dis</source>. <year>2018</year>;<volume>23</volume>:<fpage>80</fpage>–<lpage>6</lpage>. Epub 2018/04/14. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tmaid.2018.04.004</pub-id> .<?supplied-pmid 29653203?><pub-id pub-id-type="pmid">29653203</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref078">
                <label>78</label>
                <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Lau</surname><given-names>EHY</given-names></name>, <name><surname>Wu</surname><given-names>P</given-names></name>, <name><surname>Deng</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Hao</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>. <source>Nat Med</source>. <year>2020</year>;<volume>26</volume>(<issue>5</issue>):<fpage>672</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41591-020-0869-5</pub-id>
<?supplied-pmid 32296168?><pub-id pub-id-type="pmid">32296168</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref079">
                <label>79</label>
                <mixed-citation publication-type="journal"><name><surname>Wallinga</surname><given-names>J</given-names></name>, <name><surname>Teunis</surname><given-names>P</given-names></name>. <article-title>Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures</article-title>. <source>Am J Epidemiol</source>. <year>2004</year>;<volume>160</volume>(<issue>6</issue>):<fpage>509</fpage>–<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwh255</pub-id>
<?supplied-pmid 15353409?><pub-id pub-id-type="pmid">15353409</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref080">
                <label>80</label>
                <mixed-citation publication-type="journal"><name><surname>Cori</surname><given-names>A</given-names></name>, <name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Cauchemez</surname><given-names>S</given-names></name>. <article-title>A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics</article-title>. <source>Am J Epidemiol</source>. <year>2013</year>;<volume>178</volume>(<issue>9</issue>):<fpage>1505</fpage>–<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwt133</pub-id>
<?supplied-pmid 24043437?><pub-id pub-id-type="pmid">24043437</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref081">
                <label>81</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>F</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Yu</surname><given-names>B</given-names></name>, <name><surname>Chen</surname><given-names>Y-M</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Song</surname><given-names>Z-G</given-names></name>, <etal>et al</etal>. <article-title>A new coronavirus associated with human respiratory disease in China</article-title>. <source>Nature</source>. <year>2020</year>;<volume>579</volume>(<issue>7798</issue>):<fpage>265</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id>
<?supplied-pmid 32015508?><pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref082">
                <label>82</label>
                <mixed-citation publication-type="journal"><name><surname>Edgar</surname><given-names>RC</given-names></name>. <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>(<issue>5</issue>):<fpage>1792</fpage>–<lpage>7</lpage>. Epub 2004/03/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id> ; PubMed Central PMCID: PMC390337.<?supplied-pmid 15034147?><pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref083">
                <label>83</label>
                <mixed-citation publication-type="journal"><name><surname>Stamatakis</surname><given-names>A</given-names></name>. <article-title>RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies</article-title>. <source>Bioinformatics</source>. <year>2014</year>;<volume>30</volume>(<issue>9</issue>):<fpage>1312</fpage>–<lpage>3</lpage>. Epub 2014/01/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btu033</pub-id> ; PubMed Central PMCID: PMC3998144.<?supplied-pmid 24451623?><pub-id pub-id-type="pmid">24451623</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref084">
                <label>84</label>
                <mixed-citation publication-type="journal"><name><surname>Suchard</surname><given-names>MA</given-names></name>, <name><surname>Lemey</surname><given-names>P</given-names></name>, <name><surname>Baele</surname><given-names>G</given-names></name>, <name><surname>Ayres</surname><given-names>DL</given-names></name>, <name><surname>Drummond</surname><given-names>AJ</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>. <article-title>Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10</article-title>. <source>Virus Evol</source>. <year>2018</year>;<volume>4</volume>(<issue>1</issue>):<fpage>vey016</fpage>. Epub 2018/06/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ve/vey016</pub-id> ; PubMed Central PMCID: PMC6007674.<?supplied-pmid 29942656?><pub-id pub-id-type="pmid">29942656</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref085">
                <label>85</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Guan</surname><given-names>X</given-names></name>, <name><surname>Wu</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Tong</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia</article-title>. <source>NEJM</source>. <year>2020</year>; <volume>382</volume>:<fpage>1199</fpage>–<lpage>1207</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>
<?supplied-pmid 31995857?><pub-id pub-id-type="pmid">31995857</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref086">
                <label>86</label>
                <mixed-citation publication-type="journal"><name><surname>Srivastava</surname><given-names>A</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Understanding Spatial Heterogeneity of COVID-19 Pandemic Using Shape Analysis of Growth Rate Curves</article-title>. [Preprint] <source>medRxiv</source>. 2020:2020.05.25.20112433. Epub 2020 May 25. Available from: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273268/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273268/</ext-link><comment>doi: </comment><pub-id pub-id-type="doi">10.1101/2020.05.25.20112433</pub-id><?supplied-pmid 32511500?><pub-id pub-id-type="pmid">32511500</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref087">
                <label>87</label>
                <mixed-citation publication-type="book"><name><surname>Srivastava</surname><given-names>A</given-names></name>, <name><surname>Klassen</surname><given-names>EP</given-names></name>. <source>Functional and shape data analysis</source>. <edition designator="1">1st ed</edition>. <publisher-name>Springer NewYork</publisher-name>, <publisher-loc>NY</publisher-loc>; <year>2016</year>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref088">
                <label>88</label>
                <mixed-citation publication-type="other">Alliance DP. C-19 Global South obervatory Mexico 2020 [cited 2020 December 18]. Available from: <ext-link xlink:href="https://datapopalliance.org/covid19/c19globalsouthobservatory/mexico/" ext-link-type="uri">https://datapopalliance.org/covid19/c19globalsouthobservatory/mexico/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref089">
                <label>89</label>
                <mixed-citation publication-type="journal"><name><surname>Chowell</surname><given-names>G</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Hyman</surname><given-names>JM</given-names></name>, <name><surname>Simonsen</surname><given-names>L</given-names></name>. <article-title>The Western Africa Ebola virus disease epidemic exhibits both global exponential and local polynomial growth rates</article-title>. <source>PLoS Curr</source>. <year>2015</year>;<fpage>7</fpage>: ecurrents.outbreaks.8b55f4bad99ac5c5db3663e916803261. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261</pub-id> ; PubMed Central PMCID: PMC4322058.<?supplied-pmid 25685633?><pub-id pub-id-type="pmid">25685633</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref090">
                <label>90</label>
                <mixed-citation publication-type="journal"><name><surname>Mendoza</surname><given-names>CI</given-names></name>. <article-title>Inhomogeneous mixing and asynchronic transmission between local outbreaks account for the spread of COVID-19 epidemics</article-title>. <source>medRxiv</source>. 2020.08.04.20168443 [preprint]. Available from: <ext-link xlink:href="https://www.medrxiv.org/content/10.1101/2020.08.04.20168443v1" ext-link-type="uri">https://www.medrxiv.org/content/10.1101/2020.08.04.20168443v1</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref091">
                <label>91</label>
                <mixed-citation publication-type="journal"><name><surname>Tariq</surname><given-names>A</given-names></name>, <name><surname>Undurraga</surname><given-names>EA</given-names></name>, <name><surname>Laborde</surname><given-names>CC</given-names></name>, <name><surname>Vogt-Geisse</surname><given-names>K</given-names></name>, <name><surname>Luo</surname><given-names>R</given-names></name>, <name><surname>Rothenberg</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Transmission dynamics and control of COVID-19 in Chile, March-October, 2020</article-title>. <source>PLOS Negl Trop Dis</source>. <year>2021</year>;<volume>15</volume>(<issue>1</issue>):<fpage>e0009070</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0009070</pub-id><?supplied-pmid 33481804?><pub-id pub-id-type="pmid">33481804</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref092">
                <label>92</label>
                <mixed-citation publication-type="journal"><name><surname>Anzarut</surname><given-names>M</given-names></name>, <name><surname>González</surname><given-names>LF</given-names></name>, <name><surname>Mendizábal</surname><given-names>S</given-names></name>, <name><surname>Ortiz</surname><given-names>MT</given-names></name>. <article-title>Estimating COVID-19 cases and reproduction number in Mexico</article-title>. <source>arXiv:2007.09117v1</source> [preprint]. Arxiv. <year>2020</year> [cited 2020 August 2]. Available from: <ext-link xlink:href="https://arxiv.org/abs/2007.09117" ext-link-type="uri">https://arxiv.org/abs/2007.09117</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref093">
                <label>93</label>
                <mixed-citation publication-type="journal"><name><surname>Canals</surname><given-names>M</given-names></name>, <name><surname>Cuadrado</surname><given-names>C</given-names></name>, <name><surname>Canals</surname><given-names>A</given-names></name>, <name><surname>Yohannessen</surname><given-names>K</given-names></name>, <name><surname>Lefio</surname><given-names>LA</given-names></name>, <name><surname>Bertoglia</surname><given-names>MP</given-names></name>, <etal>et al</etal>. <article-title>Epidemic trends, public health response and health system capacity: the Chilean experience in four months of the COVID-19 pandemic</article-title>. <source>Rev Panam Salud Publica</source>. <year>2020</year>;<volume>44</volume>:<fpage>e99</fpage>–e. <comment>doi: </comment><pub-id pub-id-type="doi">10.26633/RPSP.2020.99</pub-id> .<?supplied-pmid 32821259?><pub-id pub-id-type="pmid">32821259</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref094">
                <label>94</label>
                <mixed-citation publication-type="journal"><name><surname>Munayco</surname><given-names>CV</given-names></name>, <name><surname>Tariq</surname><given-names>A</given-names></name>, <name><surname>Rothenberg</surname><given-names>R</given-names></name>, <name><surname>Soto-Cabezas</surname><given-names>GG</given-names></name>, <name><surname>Reyes</surname><given-names>MF</given-names></name>, <name><surname>Valle</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020</article-title>. <source>IDM</source>. <year>2020</year>;<volume>5</volume>:<fpage>338</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.idm.2020.05.001</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref095">
                <label>95</label>
                <mixed-citation publication-type="journal"><name><surname>Felix</surname><given-names>FHC</given-names></name>, <name><surname>Fontenele</surname><given-names>JB</given-names></name>. <article-title>Instantaneous R calculation for COVID-19 epidemic in Brazil</article-title>. <source>medRxiv</source>. 2020.04.23.20077172 [preprint]. Available from: <ext-link xlink:href="https://www.medrxiv.org/content/10.1101/2020.04.23.20077172v1" ext-link-type="uri">https://www.medrxiv.org/content/10.1101/2020.04.23.20077172v1</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref096">
                <label>96</label>
                <mixed-citation publication-type="other">Lopez O. Tourists Are Returning to Cancún. But Workers’ Fears About COVID-19 Never Went Away: Time; 2021 January 11 [updated January 11; cited 2021 January 14]. Available from: <ext-link xlink:href="https://time.com/5921756/mexico-tourism-coronavirus/" ext-link-type="uri">https://time.com/5921756/mexico-tourism-coronavirus/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref097">
                <label>97</label>
                <mixed-citation publication-type="other">Kitroeff N. Mexico Misled Citizens About the Severity of Coronavirus in its Capital: The Newyork Times; 2020 December 21 [cited 2020 December 29]. Available from: <ext-link xlink:href="https://www.nytimes.com/2020/12/21/world/americas/mexico-city-covid.html" ext-link-type="uri">https://www.nytimes.com/2020/12/21/world/americas/mexico-city-covid.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref098">
                <label>98</label>
                <mixed-citation publication-type="journal"><name><surname>Martinez-Valle</surname><given-names>A</given-names></name>. <article-title>Public health matters: why is Latin America struggling in addressing the pandemic?</article-title><source>J Public Health Pol</source>. 2021;<volume>42</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1057/s41271-020-00269-4</pub-id>
<?supplied-pmid 33510400?><pub-id pub-id-type="pmid">33510400</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref099">
                <label>99</label>
                <mixed-citation publication-type="journal"><name><surname>Brizuela</surname><given-names>NG</given-names></name>, <name><surname>García-Chan</surname><given-names>N</given-names></name>, <name><surname>Gutiérrez Pulido</surname><given-names>H</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Understanding the role of urban design in disease spreading</article-title>. <source>Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences</source>. <year>2021</year>;<volume>477</volume>(<issue>2245</issue>):<fpage>20200524</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1098/rspa.2020.0524</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref100">
                <label>100</label>
                <mixed-citation publication-type="other">Reuters T. Mexico officials says coronavirus cases are on a ’sustained decline’: Reuters; 2020 August 19 [cited 2020 November 6]. Available from: <ext-link xlink:href="https://www.nbcnews.com/news/latino/mexico-officials-says-coronavirus-cases-are-sustained-decline-n1237281" ext-link-type="uri">https://www.nbcnews.com/news/latino/mexico-officials-says-coronavirus-cases-are-sustained-decline-n1237281</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref101">
                <label>101</label>
                <mixed-citation publication-type="other">AP. Mexico reported 193,170 “excess deaths” through Sept 26: AP; 2020 October 25 [cited 2020 November 17]. Available from: <ext-link xlink:href="https://apnews.com/article/virus-outbreak-pandemics-health-mexico-5324b5f7aa4cc551d05e9c6cf2ed4170#:~:text=MEXICO%20CITY%20(AP)%20%E2%80%94%20Mexican,the%20year%20up%20to%20Sept" ext-link-type="uri">https://apnews.com/article/virus-outbreak-pandemics-health-mexico-5324b5f7aa4cc551d05e9c6cf2ed4170#:~:text=MEXICO%20CITY%20(AP)%20%E2%80%94%20Mexican,the%20year%20up%20to%20Sept</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref102">
                <label>102</label>
                <mixed-citation publication-type="other">Flannery NP. Why Are So Many People Dying Of Covid-19 In Mexico? Forbes; 2020 September 3 [cited 2020 October 4]. Available from: <ext-link xlink:href="https://www.forbes.com/sites/nathanielparishflannery/2020/09/03/why-are-so-many-people-dying-of-covid-19-in-mexico/?sh=5aac324218e7" ext-link-type="uri">https://www.forbes.com/sites/nathanielparishflannery/2020/09/03/why-are-so-many-people-dying-of-covid-19-in-mexico/?sh=5aac324218e7</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref103">
                <label>103</label>
                <mixed-citation publication-type="journal"><name><surname>Mahase</surname><given-names>E</given-names></name>. <article-title>Covid-19: Deaths in Mexico triple since reopening began in June</article-title>. <source>BMJ</source>. <year>2020</year>;<volume>370</volume>:<fpage>m2753</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.m2753</pub-id><?supplied-pmid 32646860?><pub-id pub-id-type="pmid">32646860</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0254826.ref104">
                <label>104</label>
                <mixed-citation publication-type="other">Daily MN. Covid deaths to stabilize in September, says Mexico City health minister: Mexico News Daily; 2020 September 30 [cited 2020 October 5]. Available from: <ext-link xlink:href="https://mexiconewsdaily.com/news/coronavirus/covid-deaths-to-stabilize-in-september-says-mexico-city-health-minister/" ext-link-type="uri">https://mexiconewsdaily.com/news/coronavirus/covid-deaths-to-stabilize-in-september-says-mexico-city-health-minister/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref105">
                <label>105</label>
                <mixed-citation publication-type="other">News B. Coronavirus: Mexico’s death toll passes 30,000 2020 July 5 [cited 2020 September 6]. Available from: <ext-link xlink:href="https://www.bbc.com/news/world-latin-america-53296003" ext-link-type="uri">https://www.bbc.com/news/world-latin-america-53296003</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0254826.ref106">
                <label>106</label>
                <mixed-citation publication-type="other">Gu Y. COVID-19 Projections Using Machine Learning 2020 [cited 2020 July 29]. Available from: <ext-link xlink:href="https://covid19-projections.com/mexico" ext-link-type="uri">https://covid19-projections.com/mexico</ext-link>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
